var title_f4_7_4208="Hyperpronation technique";
var content_f4_7_4208=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F52541&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F52541&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Hyperpronation technique",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 291px; height: 491px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    In this method, the examiner supports the child's arm at the elbow and places moderate pressure on the radial head with one finger. The examiner grips the child's distal forearm with the other hand and hyperpronates the forearm. A click may be felt by the finger over the radial head when the subluxation is reduced.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_7_4208=[""].join("\n");
var outline_f4_7_4208=null;
var title_f4_7_4209="Pinacidil: International drug information";
var content_f4_7_4209=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"10\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Pinacidil: International drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F7292215\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Pindac (IE);",
"     </li>",
"     <li>",
"      Therapress (BE, DK, LU)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1980000\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Vasodilator",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block iuse drugH1Div\" id=\"F1980003\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Reported Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Management of hypertension",
"    </p>",
"   </div>",
"   <div class=\"block idos drugH1Div\" id=\"F1979999\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Range",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adults: Oral: 12.5 mg twice daily, may increase at intervals of 1-2 weeks; maximum dose: 100-150 mg/day in divided doses",
"    </p>",
"   </div>",
"   <div class=\"block prod-avail drugH1Div\" id=\"F11821136\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Product Availability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Product available in various countries; not currently available in the U.S.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F1980002\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tablet: 12.5 mg",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10453 Version 28.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-61.234.146.186-16712FB15A-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_7_4209=[""].join("\n");
var outline_f4_7_4209=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7292215\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1980000\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1980003\">",
"      Reported Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1979999\">",
"      Dosage Range",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11821136\">",
"      Product Availability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1980002\">",
"      Dosage Forms",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_INT/10453\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_INT/10453|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f4_7_4210="Patient information: Hyperemesis gravidarum (The Basics)";
var content_f4_7_4210=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?1/39/1650\">",
"         Patient information: Morning sickness (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?40/59/41906\">",
"         Patient information: Nutrition before and during pregnancy (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?36/63/37874\">",
"         Patient information: Nausea and vomiting of pregnancy (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Hyperemesis gravidarum (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/hyperemesis-gravidarum-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H6752363\">",
"      <span class=\"h1\">",
"       What is hyperemesis gravidarum?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Hyperemesis gravidarum is a condition that causes frequent vomiting (throwing up) in pregnant women. It is like morning sickness, except the symptoms are much more severe.",
"     </p>",
"     <p>",
"      Morning sickness is the nausea and vomiting that many women have during pregnancy. Even though it is called &ldquo;morning&rdquo; sickness, symptoms can happen any time of day.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H6752378\">",
"      <span class=\"h1\">",
"       What are the symptoms of hyperemesis gravidarum?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Women with hyperemesis gravidarum vomit every day, often many times a day. Women can lose weight and get dehydrated because they are vomiting so much.",
"     </p>",
"     <p>",
"      Symptoms of dehydration include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Urinating less often than usual",
"       </li>",
"       <li>",
"        Having dark yellow urine",
"       </li>",
"       <li>",
"        Feeling dizzy when standing up",
"       </li>",
"       <li>",
"        Weight loss",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Symptoms of hyperemesis gravidarum usually start during the first 2 to 3 months of pregnancy. Most women feel better by the middle of their pregnancy. But some women feel sick until late in the pregnancy.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H6752393\">",
"      <span class=\"h1\">",
"       How can I find out if I have hyperemesis gravidarum?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Your doctor or nurse should be able to tell if you have hyperemesis gravidarum by learning about your symptoms and doing an exam.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H6752410\">",
"      <span class=\"h1\">",
"       Are there tests I should have?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Maybe. Your doctor or nurse might do tests to see if the vomiting is hurting your body and to make sure another condition isn&rsquo;t causing your symptoms. These tests can include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Blood tests",
"       </li>",
"       <li>",
"        Urine tests",
"       </li>",
"       <li>",
"        An ultrasound to check your baby",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H6752425\">",
"      <span class=\"h1\">",
"       Is there anything I can do on my own to feel better?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. To feel better, you can try the following:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Eat as soon as you feel hungry, or even before you feel hungry.",
"       </li>",
"       <li>",
"        Snack often and eat small meals. The best foods to eat are high in protein or carbohydrates, but not fat. These include crackers, bread, pretzels, nuts, and low-fat yogurt.",
"       </li>",
"       <li>",
"        Avoid foods that are spicy, greasy, or acidic (such as oranges).",
"       </li>",
"       <li>",
"        Drink cold, clear beverages, such as sports drinks and ginger&nbsp;ale. Avoid coffee. Also, try to drink between meals, rather than with a meal.",
"       </li>",
"       <li>",
"        Suck on popsicles or ginger-flavored lollipops.",
"       </li>",
"       <li>",
"        Brush your teeth right after you eat.",
"       </li>",
"       <li>",
"        Avoid lying down right after you eat.",
"       </li>",
"       <li>",
"        Take your vitamins at bedtime with a snack, not in the morning",
"       </li>",
"       <li>",
"        Avoid things in your environment that upset your stomach, such as stuffy rooms, strong smells, hot places, or loud noises.",
"       </li>",
"       <li>",
"        Have someone make your meals for you.",
"       </li>",
"       <li>",
"        Wear &ldquo;acupressure&rdquo; bands on your wrists. These are special bands that can help with morning or motion sickness.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H6752440\">",
"      <span class=\"h1\">",
"       Should I see a doctor or nurse?",
"      </span>",
"      &nbsp;&mdash;&nbsp;If you are pregnant, see your doctor or nurse right away if you have any of the symptoms listed above.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H6752455\">",
"      <span class=\"h1\">",
"       How is hyperemesis gravidarum treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Treatment depends on how severe your symptoms are. If you are dehydrated or have lost a lot of weight, you will probably need to be treated in the hospital with:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Fluids that go into your vein through a tube called an &ldquo;IV&rdquo; &nbsp;",
"       </li>",
"       <li>",
"        Medicines to help stop your nausea and vomiting",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      If this treatment doesn&rsquo;t work, your doctor can feed you through a tube that goes in your nose and down into your stomach or through a vein.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H6752470\">",
"      <span class=\"h1\">",
"       Can hyperemesis gravidarum be prevented?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Doctors strongly recommend that all women who might get pregnant or who are pregnant take vitamins. The vitamin should contain 400 micrograms of",
"      <a class=\"drug drug_patient\" href=\"UTD.htm?24/57/25492?source=see_link\">",
"       folic acid",
"      </a>",
"      . Taking vitamins before pregnancy and in early pregnancy might help prevent nausea and vomiting.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H6752485\">",
"      <span class=\"h1\">",
"       Will my baby be healthy?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Babies born to women with hyperemesis gravidarum",
"      <strong>",
"      </strong>",
"      for the entire pregnancy are a little more likely to be smaller than average. But otherwise, the condition doesn&rsquo;t seem to cause problems. Taking medicines for nausea and vomiting during the pregnancy should not affect the baby either.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H6752502\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?1/39/1650?source=see_link\">",
"       Patient information: Morning sickness (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?40/59/41906?source=see_link\">",
"       Patient information: Nutrition before and during pregnancy (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?36/63/37874?source=see_link\">",
"       Patient information: Nausea and vomiting of pregnancy (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?4/7/4210?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 16988 Version 1.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-27.109.116.13-FFFC22E1CE-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_7_4210=[""].join("\n");
var outline_f4_7_4210=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6752363\">",
"      What is hyperemesis gravidarum?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6752378\">",
"      What are the symptoms of hyperemesis gravidarum?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6752393\">",
"      How can I find out if I have hyperemesis gravidarum?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6752410\">",
"      Are there tests I should have?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6752425\">",
"      Is there anything I can do on my own to feel better?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6752440\">",
"      Should I see a doctor or nurse?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6752455\">",
"      How is hyperemesis gravidarum treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6752470\">",
"      Can hyperemesis gravidarum be prevented?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6752485\">",
"      Will my baby be healthy?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6752502\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?1/39/1650?source=related_link\">",
"      Patient information: Morning sickness (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?36/63/37874?source=related_link\">",
"      Patient information: Nausea and vomiting of pregnancy (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?40/59/41906?source=related_link\">",
"      Patient information: Nutrition before and during pregnancy (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f4_7_4211="Metastatic breast cancer involving the mandible";
var content_f4_7_4211=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F85780&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F85780&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 604px\">",
"   <div class=\"ttl\">",
"    Metastatic breast cancer involving the mandible",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 584px; height: 220px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A) Notable facial swelling due to tumor growth, with associated neural deficiency.",
"    <br/>",
"    (B) Coronal CT image demonstrating extensive bone destruction and a large soft tissue mass.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Nathaniel Treister, DMD, DMSc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_7_4211=[""].join("\n");
var outline_f4_7_4211=null;
var title_f4_7_4212="RML and RLL atelectasis I";
var content_f4_7_4212=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F52547&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F52547&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Combined right middle and right lower lobe atelectasis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 338px; height: 350px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Upright chest radiograph showing atelectasis in the right middle and lower lobes after cholecystectomy. The prominent findings include elevation of the right lung base (arrow) with obscuring of the right hilar structures, basilar pulmonary vessels, and right heart border. This radiograph was initially interpreted as a subpulmonic effusion.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Normal chest radiograph",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 371px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Posteroanterior view of a normal chest radiograph.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Carol M Black, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_7_4212=[""].join("\n");
var outline_f4_7_4212=null;
var title_f4_7_4213="IncobotulinumtoxinA (botulinum toxin type A, Xeomin): Patient drug information";
var content_f4_7_4213=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   IncobotulinumtoxinA (botulinum toxin type A, Xeomin): Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/48/43781?source=see_link\">",
"     see \"IncobotulinumtoxinA (botulinum toxin type A, Xeomin): Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F10894929\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Xeomin&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F10826168\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Xeomin Cosmetic&trade;;",
"     </li>",
"     <li>",
"      Xeomin&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10907924\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700505",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad side effects have happened when this drug has spread from where it is being used.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700454",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug comes with an extra patient fact sheet called a Medication Guide. Read it with care. Read it again each time this drug is refilled.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10907925\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691970",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat muscle problems around the eye.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691971",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat muscle problems that lead to spasms.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692091",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat spasms of the head. It may take 2 weeks to get better.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691338",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to lower the number of lines and wrinkles of the face and neck.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10901119\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2920240",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to incobotulinumtoxinA, albumin, or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703160",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an infection where the shot will be given.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703746",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have had a botulinum toxin product in the last 3 or 4 months.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10901121\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697184",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have bleeding problems, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697300",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have lung disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697314",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have nerve disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697344",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have trouble swallowing, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10907928\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698189",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Irritation where the shot is given.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698253",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Muscle weakness or changes in eyesight may happen. Avoid driving and doing other tasks or actions that call for you to be alert or have clear eyesight until you see how this drug affects you.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698277",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Neck pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698027",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dry mouth. Good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help. See a dentist often.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697989",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Less blinking.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698018",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Seeing double.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dry eyes. Using artificial tears may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Eyelid droop.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698377",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Ulcers may  rarely happen.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698324",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad bleeding may rarely happen.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10901123\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699077",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of infection. These include a fever of 100.5&deg;F (38&deg;C) or higher, chills, very bad sore throat, ear or sinus pain, cough, more sputum or change in color of sputum, pain with passing urine, mouth sores, wound that will not heal, or anal itching or pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698643",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble swallowing or speaking.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699038",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad muscle pain or weakness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699086",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sudden change in eyesight, eye pain, or irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699100",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to control bladder.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10907927\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696004",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into the muscle(s) causing the spasms.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10901120\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696445",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Call your doctor for an office visit.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10908344\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699585",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       The shot will be given to you in a hospital or doctor's office. You will not store it at home.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10901264\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 16070 Version 22.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1002-222.190.118.195-160F99BB66-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_7_4213=[""].join("\n");
var outline_f4_7_4213=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10894929\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10826168\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10907924\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10907925\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10901119\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10901121\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10907928\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10901123\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10907927\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10901120\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10908344\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10901264\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?42/48/43781?source=related_link\">",
"      IncobotulinumtoxinA (botulinum toxin type A, Xeomin): Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f4_7_4214="Rosacea keratitis";
var content_f4_7_4214=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F72305&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F72305&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 516px\">",
"   <div class=\"ttl\">",
"    Rosacea keratitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 496px; height: 351px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Active keratitis. The cornea is invaded by two prominent vascular leashes showing active infiltration at their central tips. In addition, there is marked bulbar conjunctival hyperemia and a circumferential pannus. There is also gross obstructive meibomian gland dysfunction.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Gary Foulks, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_7_4214=[""].join("\n");
var outline_f4_7_4214=null;
var title_f4_7_4215="Overview of nutritional support for moderate to severe burn patients";
var content_f4_7_4215=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Overview of nutritional support for moderate to severe burn patients",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?4/7/4215/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?4/7/4215/contributors\">",
"     Amalia Cochran, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?4/7/4215/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?4/7/4215/contributors\">",
"     Marc G Jeschke, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?4/7/4215/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?4/7/4215/contributors\">",
"     Rosemary B Duda, MD, MPH, FACS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?4/7/4215/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 12, 2010.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nutritional support represents one of the most important cornerstones in the management of patients with a moderate to severe burn injury. Management of nutritional needs in burn patients has many features in common with the nutritional management of other critically ill surgical patients. However, the severity, magnitude and duration of the hypermetabolic response and the ensuing energy requirements for the severe burn patient are far greater than other critically ill patients.",
"   </p>",
"   <p>",
"    The unique characteristics of nutritional requirements in the moderate and severe burn patient, including patient selection, initiation, and delivery of nutritional support will be discussed here.",
"   </p>",
"   <p>",
"    Other aspects of nutritional support in burn patients are reviewed separately:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/51/22330?source=see_link\">",
"       \"Hypermetabolic response to severe burn injury: Recognition and treatment\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/8/11401?source=see_link\">",
"       \"Nutritional demands and enteral formulas for moderate to severe burn patients\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?15/22/15716?source=see_link\">",
"       \"Evaluating nutritional support for moderate to severe burn patients\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DEFINITION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nutritional support is the provision of nutrients and any necessary adjunctive therapeutic agents to improve or maintain the nutritional status. Nutritional support is administered into the stomach or small intestine (enteral)",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    by intravenous infusion (parenteral) [",
"    <a class=\"abstract\" href=\"UTD.htm?4/7/4215/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PRIMARY GOAL",
"    </span>",
"    &nbsp;&mdash;&nbsp;The primary goal of nutritional support following severe burn injury is to meet the distinctive demands placed upon the body by hypermetabolism. The adverse effects of the hypermetabolic response can result in life-threatening protein-calorie malnutrition. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/51/22330?source=see_link\">",
"     \"Hypermetabolic response to severe burn injury: Recognition and treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The specific areas of concern that must be addressed in the burn patients include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Maintenance of lean body mass",
"     </li>",
"     <li>",
"      Limitation of fat accretion and protein wasting",
"     </li>",
"     <li>",
"      Assisting and enhancing wound healing",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Enteral nutrition, which is administered through a nasogastric, gastric or intestinal tube, is the preferred method of feeding the critically ill patient and an important means of counteracting hypermetabolism. Supplementary parenteral nutrition should be given only to those patients who do not reach their target nutrient intake on enteral feedings alone [",
"    <a class=\"abstract\" href=\"UTD.htm?4/7/4215/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     PATIENT SELECTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although provision of adequate nutrition is vital in all burn injuries, identification of patients who require coordinated nutritional support is a key component of the comprehensive care of the patient with moderate to severe burns. However, there is limited evidence to support the decision-making process and the timing of the initiation of nutritional support in the critical care setting. Consultation with a dietitian experienced in the nutritional care of burn patients can prove exceptionally helpful in all aspects of the nutritional care of these patients.",
"   </p>",
"   <p>",
"    Identification of patients who are likely to require coordinated nutritional support presents a substantial challenge because of the heterogeneity of the metabolic response and the burn injury patterns. The European Society for Clinical Nutrition and Metabolism (ESPEN), a multidisciplinary expert group, formulated nutritional guidelines based on six randomized controlled trials that met their study criteria [",
"    <a class=\"abstract\" href=\"UTD.htm?4/7/4215/abstract/2\">",
"     2",
"    </a>",
"    ]. In their consensus statement, the ESPEN recommends enteral nutrition be provided to all critically ill patients, including severe burn patients, who will not be initiating oral nutrition within three days of the injury or illness.",
"   </p>",
"   <p>",
"    Patients with moderate to severe burn injuries as well as those with the following conditions should receive enteral nutritional support to meet energy requirements [",
"    <a class=\"abstract\" href=\"UTD.htm?4/7/4215/abstract/2\">",
"     2",
"    </a>",
"    ]",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Sepsis",
"     </li>",
"     <li>",
"      Unable to tolerate oral feedings",
"     </li>",
"     <li>",
"      Unable to sustain themselves on oral intake alone",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Nutritional support is used selectively in patients with minor (&lt;20 percent) burn injury. Some groups that may benefit include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Children",
"     </li>",
"     <li>",
"      Elderly",
"     </li>",
"     <li>",
"      Patients with metabolic syndrome",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Moderate and severe burns",
"    </span>",
"    &nbsp;&mdash;&nbsp;The American Burn Association burn injury severity grading system groups burns into minor, moderate and major (severe) categories (",
"    <a class=\"graphic graphic_table graphicRef74855 \" href=\"UTD.htm?2/13/2268\">",
"     table 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?4/7/4215/abstract/3\">",
"     3",
"    </a>",
"    ]. The metabolic rate increases proportionally to the increase in burn size [",
"    <a class=\"abstract\" href=\"UTD.htm?4/7/4215/abstract/4\">",
"     4",
"    </a>",
"    ]. A 15 to 25 percent total body surface area (TBSA) burn injury initiates a catabolic response, including impaired immunity and fluid shifts [",
"    <a class=\"abstract\" href=\"UTD.htm?4/7/4215/abstract/5\">",
"     5",
"    </a>",
"    ]. Those patients with burns greater than 40 percent TBSA consistently experience hypermetabolism [",
"    <a class=\"abstract\" href=\"UTD.htm?4/7/4215/abstract/6\">",
"     6",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/51/22330?source=see_link&amp;anchor=H4#H4\">",
"     \"Hypermetabolic response to severe burn injury: Recognition and treatment\", section on 'Frequency'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Delayed oral intake",
"    </span>",
"    &nbsp;&mdash;&nbsp;In our center, burn patients who are not expected to initiate an oral diet within three days of sustaining the burn injury are started on nutritional support. Patients who have sustained an inhalation injury or who have extensive facial burns, both of which are likely to result in a prolonged ventilator course, most likely meet this criterion.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Failure to thrive",
"    </span>",
"    &nbsp;&mdash;&nbsp;Failure to maintain lean body mass (LBM) and body weight with oral intake is an indication for nutritional support. Patients with moderate burns that involve 20 to 40 percent of TBSA may not be able to consume sufficient calories to maintain LBM and weight [",
"    <a class=\"abstract\" href=\"UTD.htm?4/7/4215/abstract/7\">",
"     7",
"    </a>",
"    ]. Similarly, patients who require extensive surgery, develop complications of their injury, or have a known nutritional deficiency at the time of admission may not consume adequate calories [",
"    <a class=\"abstract\" href=\"UTD.htm?4/7/4215/abstract/8,9\">",
"     8,9",
"    </a>",
"    ]. Nutritional support following burn injury is unlikely to redress preexisting conditions, but instead is designed to treat the metabolic demands incurred as a result of the burn injury [",
"    <a class=\"abstract\" href=\"UTD.htm?4/7/4215/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Children",
"    </span>",
"    &nbsp;&mdash;&nbsp;Children are more vulnerable to the metabolic demands and consequences of a burn injury [",
"    <a class=\"abstract\" href=\"UTD.htm?4/7/4215/abstract/10\">",
"     10",
"    </a>",
"    ]. They have greater basal metabolic requirements than adults per unit of weight because of energy needed to sustain growth and activity. Children also mount a hypermetabolic response to burns comparable to the response seen in adults, but have relatively limited energy reserves when compared to adults.",
"   </p>",
"   <p>",
"    Oral intake in burned children may prove particularly challenging because of pain and anxiety, as well as the inability of younger children to comprehend the importance of adequate oral intake. The psychological aspects of nutrition coupled with the deleterious effects of acute protein-calorie malnutrition mean that enteral nutritional support may be started in children earlier and with less severe injuries than in adults [",
"    <a class=\"abstract\" href=\"UTD.htm?4/7/4215/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Elderly",
"    </span>",
"    &nbsp;&mdash;&nbsp;Elderly patients with burn injuries may provide a particular challenge in nutritional management for a variety of reasons. Because of immunosenescence, the elderly do not heal wounds as readily as their younger counterparts. Elderly patients have a higher incidence of malnutrition at the time of injury, which may result in poorer outcomes unless nutritional status is effectively addressed [",
"    <a class=\"abstract\" href=\"UTD.htm?4/7/4215/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Under normal circumstances, the elderly have a decreased resting metabolic rate and may be unable to generate an increase in metabolism to meet the demands of a burn injury. Finally, because of underlying organ dysfunction consequent to aging or true medical comorbidities, limitation of some macronutrients (eg, protein, fat) and micronutrients (eg, potassium, glucose) may be appropriate in the elderly burned patient [",
"    <a class=\"abstract\" href=\"UTD.htm?4/7/4215/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Metabolic syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Metabolic syndrome includes six components of illness in which patients are at increased risk of cardiovascular disease. These six components include abdominal obesity, atherogenic dyslipidemia, hypertension, insulin resistance with or without glucose intolerance, proinflammatory state and prothrombotic state [",
"    <a class=\"abstract\" href=\"UTD.htm?4/7/4215/abstract/14\">",
"     14",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/11/32954?source=see_link\">",
"     \"The metabolic syndrome (insulin resistance syndrome or syndrome X)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Metabolic syndrome patients who sustain burn injury provide a nutrition management challenge. Glycemic control can prove even more difficult in patients who are already predisposed to insulin resistance and hyperglycemia. Obesity often lends a false sense of security that patients are well nourished when, in fact, the converse is true. Obese patients typically have decreased visceral protein stores and muscle mass, and the hormonal response of hypermetabolism limits the body's ability to use fat stores as an energy source [",
"    <a class=\"abstract\" href=\"UTD.htm?4/7/4215/abstract/9\">",
"     9",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/23/28023?source=see_link\">",
"     \"Glycemic control and intensive insulin therapy in critical illness\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/51/22330?source=see_link\">",
"     \"Hypermetabolic response to severe burn injury: Recognition and treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Calculation of nutritional needs in obese patients with burn injury adds another nuance to their care [",
"    <a class=\"abstract\" href=\"UTD.htm?4/7/4215/abstract/15\">",
"     15",
"    </a>",
"    ]. The metabolic syndrome and its associated manifestations obscure an already complicated process of determining which burn patients require nutritional support.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     INITIATION OF NUTRITIONAL SUPPORT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although providing nutrition is accepted to be essential in the successful management of the burn patient, the timing of initiating nutritional support is controversial. While there may be a trend towards decreased infection rates and decreased calorie deficits, the safety and efficacy of early support has not been conclusively established [",
"    <a class=\"abstract\" href=\"UTD.htm?4/7/4215/abstract/16-18\">",
"     16-18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A meta-analysis of three randomized, controlled trials involving 70 adult burn patients that evaluated early (within 24 hours) versus late (after 24 hours) enteral nutritional support found no significant benefit of early enteral feedings [",
"    <a class=\"abstract\" href=\"UTD.htm?4/7/4215/abstract/19\">",
"     19",
"    </a>",
"    ]. Clinical outcomes of length of hospital stay, infection or mortality were similar in both groups, but it remains unclear whether early enteral nutritional support has any beneficial impact on a diverse field of nutritional, metabolic and biochemical outcome markers. The trials showed some promising results that would suggest early enteral nutrition support may attenuate the hyperbolic response, but are insufficient to provide clear guidelines for practice. This meta-analysis was limited by methodological weakness including the few number of patients, lack of description of burn depth, and only one study reporting on each: mortality, length of hospital stay, rate of infections and number of adverse events.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Clinical practice",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the hemodynamically stable patient, with a 20 to 80 percent burn, we suggest initiating nutritional support in the form of enteral feeding by day two. In unstable patients, nutritional support should be started as soon as patients can tolerate enteral feedings [",
"    <a class=\"abstract\" href=\"UTD.htm?4/7/4215/abstract/2,8,20\">",
"     2,8,20",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/17/34073?source=see_link\">",
"     \"Nutrition support in critically ill patients: Enteral nutrition\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/58/8102?source=see_link\">",
"     \"Nutrition support in critically ill patients: Parenteral nutrition\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/32/6664?source=see_link\">",
"     \"Perioperative nutritional support\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/51/22330?source=see_link\">",
"     \"Hypermetabolic response to severe burn injury: Recognition and treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     DELIVERY OF NUTRITIONAL SUPPORT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The two methods of delivering nutritional support, exclusive of oral intake, are the enteral route and the parenteral route. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/51/22330?source=see_link\">",
"     \"Hypermetabolic response to severe burn injury: Recognition and treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Enteral",
"    </span>",
"    &nbsp;&mdash;&nbsp;The enteral route is preferred in burn patients who require nutritional support because of the maintenance of intestinal integrity and associated immunity [",
"    <a class=\"abstract\" href=\"UTD.htm?4/7/4215/abstract/21\">",
"     21",
"    </a>",
"    ]. Enteral nutritional support can be delivered through the stomach or the small intestine.",
"   </p>",
"   <p>",
"    The practice at our burn center is to place a nasoenteric feeding tube at the bedside in all patients with moderate to severe burn injury within 48 hours of admission. We use fluoroscopy to place the tube past the ligament of Treitz. Enteral feedings are initiated at a low rate and increased to an established goal rate over the next 12 to 18 hours. We only provide gastric feedings when the tube cannot be advanced past the pylorus; however, many burn centers safely and successfully use only gastric feedings or use a combination of gastric and enteric feedings.",
"   </p>",
"   <p>",
"    The effectiveness of gastric versus intestinal nutritional support remains an area of controversy in burn care. Either modality of enteral nutrition is acceptable in the ICU setting. Gastric feeding is preferred although intestinal feedings may become necessary if a patient has a particularly high risk for aspiration or has demonstrated intolerance for gastric nutritional support [",
"    <a class=\"abstract\" href=\"UTD.htm?4/7/4215/abstract/2,8\">",
"     2,8",
"    </a>",
"    ]. The low risk of aspiration with intestinal feedings allow them to be continued during patient repositioning, wound care, and even through operative procedures [",
"    <a class=\"abstract\" href=\"UTD.htm?4/7/4215/abstract/22,23\">",
"     22,23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Prompt initiation of gastric feedings following injury decreases gastroparesis. Advantages of gastric nutritional support include the ease of tube placement, the decreased incidence of diarrhea, and the beneficial impact on stress ulcer prophylaxis. The key disadvantage of gastric nutritional support is that many moderate to severe burn patients require multiple operative procedures frequently requiring that gastric feedings be stopped perioperatively to decrease the risk of aspiration. If nutritional support cannot be established within the first 24 to 48 hours following a burn injury, the small bowel is less affected by post-burn ileus than the stomach, and intestinal feeding may therefore be better tolerated [",
"    <a class=\"abstract\" href=\"UTD.htm?4/7/4215/abstract/22,24\">",
"     22,24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Placement of an intestinal tube is technically more difficult than placement of a gastric tube. Although there is a greater risk of dislodgment with the intestinal tube, the ability to feed through sepsis and operative procedures provides a slight advantage over gastric feeding in catastrophic burns [",
"    <a class=\"abstract\" href=\"UTD.htm?4/7/4215/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Parenteral",
"    </span>",
"    &nbsp;&mdash;&nbsp;Parenteral nutrition is indicated if the burn patient cannot tolerate enteral feedings [",
"    <a class=\"abstract\" href=\"UTD.htm?4/7/4215/abstract/10\">",
"     10",
"    </a>",
"    ]. Burn patients with severe diarrhea, abdominal pain or ileus or those who have had previous gastrointestinal problems and cannot receive sufficient calories via the enteral route are candidates for parenteral nutritional support.",
"   </p>",
"   <p>",
"    Parenteral nutritional support should be provided through a central venous catheter. Peripheral nutritional support will not provide adequate calories to meet the metabolic demands from a severe burn injury.",
"   </p>",
"   <p>",
"    In a retrospective review of 67 burn patients, septic and metabolic complications were significantly reduced in patients who received enteral nutrition (n = 33) versus a similar cohort who received parenteral nutrition (n = 34) [",
"    <a class=\"abstract\" href=\"UTD.htm?4/7/4215/abstract/25\">",
"     25",
"    </a>",
"    ]. There was no statistical difference in age, gender or TBSA burn, or length of hospital stay between the two groups. Those who received enteral nutritional support had significantly higher serum prealbumin and transferrin levels, and fewer hypoglycemic events, electrolyte abnormalities, pulmonary complications, sepsis and mortality.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Combination therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Supplementation of enteral nutrition with parenteral nutrition in burn patients has been associated with a significant increase in mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?4/7/4215/abstract/26,27\">",
"     26,27",
"    </a>",
"    ]. A randomized trial of 39 patients with greater than 50 percent TBSA burn found that aggressive high-calorie feeding with a combination of enteral and parenteral nutrition was associated with significantly higher mortality than enteral feedings alone (63 and 26 percent, respectively). Intravenous supplementation decreased the amount of enteral calories tolerated by burn patients [",
"    <a class=\"abstract\" href=\"UTD.htm?4/7/4215/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Therefore, parenteral nutrition is appropriate only in those burn patients who have prolonged intolerance to enteral feeds and who are absolutely unable to attain adequate protein and calorie intake on enteral nutrition or who suffer with burns that limit access to the stomach or small intestines [",
"    <a class=\"abstract\" href=\"UTD.htm?4/7/4215/abstract/9,28\">",
"     9,28",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/51/22330?source=see_link\">",
"     \"Hypermetabolic response to severe burn injury: Recognition and treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     CALORIC REQUIREMENTS AND ENTERAL FORMULAS",
"    </span>",
"    &nbsp;&mdash;&nbsp;This topic is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/8/11401?source=see_link\">",
"     \"Nutritional demands and enteral formulas for moderate to severe burn patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     EVALUATING NUTRITIONAL SUPPORT",
"    </span>",
"    &nbsp;&mdash;&nbsp;(see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/22/15716?source=see_link\">",
"     \"Evaluating nutritional support for moderate to severe burn patients\"",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nutritional support represents one of the most important cornerstones in the management of patients with a moderate to severe burn injury. The severity, magnitude and duration of the hypermetabolic response and the ensuing energy requirements are far greater than other critically ill patients. (See",
"    <a class=\"local\" href=\"#H1\">",
"     'Introduction'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The primary goal of nutritional support following severe burn injury is to meet the distinctive demands placed upon the body by hypermetabolism. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Primary goal'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Provision of adequate nutrition is vital in all burn injuries. The high-risk groups include patients with severe burns and moderate burns. Burn patients with sepsis, delayed oral intake, failure to thrive on oral feedings, children, elderly, and the metabolic syndrome require evaluation for enteral nutritional support. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Patient selection'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest that enteral nutritional support be initiated within 24 to 48 hours of the burn injury in the stable patient who otherwise will not be able to consume sufficient oral calories (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Initiation of nutritional support'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest that enteral nutrition be the first-line nutritional support in the burn patient who cannot consume all required calories orally (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Delivery of nutritional support'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend avoiding the combination of enteral and parenteral nutritional support (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Delivery of nutritional support'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Our preferred delivery of enteral nutritional is nasoenteric tube. Although there is a greater risk of dislodgment with the intestinal tube, the ability to feed through sepsis and operative procedures provides a slight advantage over gastric feeding in catastrophic burns. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Delivery of nutritional support'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     National Collaborating Centre for Acute Care. Nutrition support in adults: Oral nutrition support, enteral tube feeding and parenteral nutrition. Methods, evidence &amp; guidance. National Collaborating Centre for Acute Care, London 2006. Available online at: www.nice.org.uk/nicemedia/pdf/cg032fullguideline.pdf (Accessed on January 14, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/7/4215/abstract/2\">",
"      Kreymann KG, Berger MM, Deutz NE, et al. ESPEN Guidelines on Enteral Nutrition: Intensive care. Clin Nutr 2006; 25:210.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/7/4215/abstract/3\">",
"      Hospital and prehospital resources for optimal care of patients with burn injury: guidelines for development and operation of burn centers. American Burn Association. J Burn Care Rehabil 1990; 11:98.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/7/4215/abstract/4\">",
"      Jeschke MG, Barrow RE, Herndon DN. Extended hypermetabolic response of the liver in severely burned pediatric patients. Arch Surg 2004; 139:641.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/7/4215/abstract/5\">",
"      Deitch EA. Nutritional support of the burn patient. Crit Care Clin 1995; 11:735.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/7/4215/abstract/6\">",
"      Pereira CT, Herndon DN. The pharmacologic modulation of the hypermetabolic response to burns. Adv Surg 2005; 39:245.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/7/4215/abstract/7\">",
"      Newsome TW, Mason AD Jr, Pruitt BA Jr. Weight loss following thermal injury. Ann Surg 1973; 178:215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/7/4215/abstract/8\">",
"      Martindale RG, McClave SA, Vanek VW, et al. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine and American Society for Parenteral and Enteral Nutrition: Executive Summary. Crit Care Med 2009; 37:1757.",
"     </a>",
"    </li>",
"    <li>",
"     Saffle, JR, Graves, C. Nutritional support of the burned patient. In: Total Burn Care, 3rd Edition, Herndon, DN (Ed), Saunders Elsevier, Philadelphia, PA 2007. p.398.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/7/4215/abstract/10\">",
"      Chan MM, Chan GM. Nutritional therapy for burns in children and adults. Nutrition 2009; 25:261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/7/4215/abstract/11\">",
"      Pollack MM, Ruttimann UE, Wiley JS. Nutritional depletions in critically ill children: associations with physiologic instability and increased quantity of care. JPEN J Parenter Enteral Nutr 1985; 9:309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/7/4215/abstract/12\">",
"      Demling RH. The incidence and impact of pre-existing protein energy malnutrition on outcome in the elderly burn patient population. J Burn Care Rehabil 2005; 26:94.",
"     </a>",
"    </li>",
"    <li>",
"     Sullivan, DH, Johnson, LE, Chapter 38. Nutrition and Aging. Halter JB, Ouslander JG, Tinetti ME, Studenski S, High, KP, Asthana S: Hazzard's Geriatric Medicine and Gerontology, www.accessmedicine.com.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/7/4215/abstract/14\">",
"      Grundy SM, Brewer HB Jr, Cleeman JI, et al. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004; 109:433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/7/4215/abstract/15\">",
"      Dickerson RN, Boschert KJ, Kudsk KA, Brown RO. Hypocaloric enteral tube feeding in critically ill obese patients. Nutrition 2002; 18:241.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/7/4215/abstract/16\">",
"      Gottschlich MM, Jenkins ME, Mayes T, et al. The 2002 Clinical Research Award. An evaluation of the safety of early vs delayed enteral support and effects on clinical, nutritional, and endocrine outcomes after severe burns. J Burn Care Rehabil 2002; 23:401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/7/4215/abstract/17\">",
"      Jenkins, ME, Gottschlich, MM, Alexander, JW, Warden, GD. Effect of immediate enteral feeding on the hypermetabolic response following burn injury. JPEN J Parenter Enteral Nutr 1989; 13:12S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/7/4215/abstract/18\">",
"      Peck MD, Kessler M, Cairns BA, et al. Early enteral nutrition does not decrease hypermetabolism associated with burn injury. J Trauma 2004; 57:1143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/7/4215/abstract/19\">",
"      Wasiak J, Cleland H, Jeffery R. Early versus delayed enteral nutrition support for burn injuries. Cochrane Database Syst Rev 2006; :CD005489.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/7/4215/abstract/20\">",
"      Ebell MH, Siwek J, Weiss BD, et al. Strength of recommendation taxonomy (SORT): a patient-centered approach to grading evidence in the medical literature. Am Fam Physician 2004; 69:548.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/7/4215/abstract/21\">",
"      Alverdy J, Chi HS, Sheldon GF. The effect of parenteral nutrition on gastrointestinal immunity. The importance of enteral stimulation. Ann Surg 1985; 202:681.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/7/4215/abstract/22\">",
"      Prelack K, Dylewski M, Sheridan RL. Practical guidelines for nutritional management of burn injury and recovery. Burns 2007; 33:14.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/7/4215/abstract/23\">",
"      Mayes T, Gottschlich MM, Warden GD. Clinical nutrition protocols for continuous quality improvements in the outcomes of patients with burns. J Burn Care Rehabil 1997; 18:365.",
"     </a>",
"    </li>",
"    <li>",
"     Norbury, WB, Herndon, DN. Modulation of the hypermetabolic response after burn injury. In: Total Burn Care, 3rd Edition, Herndon, DN (Ed), Saunders Elsevier, Philadelphia, PA 2007. p. 420.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/7/4215/abstract/25\">",
"      Basaran, O, Uysal, S, Kesik, E, Kut, A. Comparison of frequency of complications in burn patients receiving enteral versus parenteral nutrition. Burns 2007; 33S:S44.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/7/4215/abstract/26\">",
"      Herndon DN, Barrow RE, Stein M, et al. Increased mortality with intravenous supplemental feeding in severely burned patients. J Burn Care Rehabil 1989; 10:309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/7/4215/abstract/27\">",
"      Herndon DN, Stein MD, Rutan TC, et al. Failure of TPN supplementation to improve liver function, immunity, and mortality in thermally injured patients. J Trauma 1987; 27:195.",
"     </a>",
"    </li>",
"    <li>",
"     Baytieh, L, Carr-Thompson, A, Fox, V, et al. Nutrition and dietetics principles and guidelines for adult and pediatric burns patient management. New South Wales Severe Burn Injury Service, Sydney, Australia 2004. Available online at: www.health.nsw.gov.au/resources/gmct/burninjury/pdf/nutrition_burns_cpgs.pdf (Accessed on April 27, 2010).",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 821 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-83.177.194.223-DD2D800F1C-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_7_4215=[""].join("\n");
var outline_f4_7_4215=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H19\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DEFINITION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PRIMARY GOAL",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      PATIENT SELECTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Moderate and severe burns",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Delayed oral intake",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Failure to thrive",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Children",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Elderly",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Metabolic syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      INITIATION OF NUTRITIONAL SUPPORT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Clinical practice",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      DELIVERY OF NUTRITIONAL SUPPORT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Enteral",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Parenteral",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Combination therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      CALORIC REQUIREMENTS AND ENTERAL FORMULAS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      EVALUATING NUTRITIONAL SUPPORT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"SURG/821\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/821|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?2/13/2268\" title=\"table 1\">",
"      American Burn Association grade",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/22/15716?source=related_link\">",
"      Evaluating nutritional support for moderate to severe burn patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/23/28023?source=related_link\">",
"      Glycemic control and intensive insulin therapy in critical illness",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/51/22330?source=related_link\">",
"      Hypermetabolic response to severe burn injury: Recognition and treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/17/34073?source=related_link\">",
"      Nutrition support in critically ill patients: Enteral nutrition",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/58/8102?source=related_link\">",
"      Nutrition support in critically ill patients: Parenteral nutrition",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/8/11401?source=related_link\">",
"      Nutritional demands and enteral formulas for moderate to severe burn patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/32/6664?source=related_link\">",
"      Perioperative nutritional support",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/11/32954?source=related_link\">",
"      The metabolic syndrome (insulin resistance syndrome or syndrome X)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f4_7_4216="Treatment of skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus in adults";
var content_f4_7_4216=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Treatment of skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus in adults",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?4/7/4216/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?4/7/4216/contributors\">",
"     Franklin D Lowy, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?4/7/4216/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?4/7/4216/contributors\">",
"     Daniel J Sexton, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?4/7/4216/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?4/7/4216/contributors\">",
"     Elinor L Baron, MD, DTMH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?4/7/4216/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 25, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Methicillin resistance in Staphylococcus aureus is defined as an",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/15/8437?source=see_link\">",
"     oxacillin",
"    </a>",
"    minimum inhibitory concentration (MIC) &ge;4",
"    <span class=\"nowrap\">",
"     mcg/mL.",
"    </span>",
"    Isolates resistant to oxacillin or methicillin are also resistant to most other beta-lactam agents including",
"    <a class=\"drug drug_general\" href=\"UTD.htm?3/11/3253?source=see_link\">",
"     dicloxacillin",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/2/4136?source=see_link\">",
"     cefazolin",
"    </a>",
"    . However,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/33/4628?source=see_link\">",
"     ceftaroline",
"    </a>",
"    is a beta-lactam that does have activity against methicillin-resistant staphylococci. [",
"    <a class=\"abstract\" href=\"UTD.htm?4/7/4216/abstract/1,2\">",
"     1,2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The treatment of MRSA skin and soft tissue infections in adults will be reviewed here. The treatment of invasive MRSA infections, the mechanisms of antibiotic resistance, epidemiology of MRSA infection, and general issues related to skin and soft tissue infections are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/48/21258?source=see_link\">",
"     \"Treatment of invasive methicillin-resistant Staphylococcus aureus infections in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/13/15575?source=see_link\">",
"     \"Microbiology of methicillin-resistant Staphylococcus aureus\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/53/8026?source=see_link\">",
"     \"Epidemiology of methicillin-resistant Staphylococcus aureus infection in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/33/12825?source=see_link\">",
"     \"Cellulitis and erysipelas\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/51/43831?source=see_link\">",
"     \"Skin abscesses, furuncles, and carbuncles\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/21/21846?source=see_link\">",
"     \"Impetigo\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/55/22387?source=see_link\">",
"     \"Folliculitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     APPROACH TO TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Given the increasing prevalence of methicillin-resistant Staphylococcus aureus (MRSA) as both a nosocomial and community-associated pathogen, beta-lactam antibiotics are no longer reliable empiric therapy for skin and soft tissue infections [",
"    <a class=\"abstract\" href=\"UTD.htm?4/7/4216/abstract/3\">",
"     3",
"    </a>",
"    ]. Familiarity with local antibiotic patterns is important for selecting empiric antibiotic therapy, and culture with susceptibility data is critical for tailoring treatment. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/53/8026?source=see_link\">",
"     \"Epidemiology of methicillin-resistant Staphylococcus aureus infection in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The approach to treatment is guided by the type of skin and soft tissue infection and the severity of clinical presentation. Empiric antibiotic therapy should include MRSA coverage if MRSA is suspected based upon local epidemiology; risk factors or the clinical features are not sufficient to make this determination [",
"    <a class=\"abstract\" href=\"UTD.htm?4/7/4216/abstract/4-6\">",
"     4-6",
"    </a>",
"    ]. Although many patients with MRSA infection have nasal colonization with the same strain that is responsible for the infection, the predictive value of screening for colonization in the outpatient setting is not proven [",
"    <a class=\"abstract\" href=\"UTD.htm?4/7/4216/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients with fluctuant or purulent skin and soft tissue infections should undergo incision and drainage, and debrided material should be sent for culture and susceptibility testing [",
"    <a class=\"abstract\" href=\"UTD.htm?4/7/4216/abstract/8\">",
"     8",
"    </a>",
"    ]. Incision and drainage alone may be sufficient for abscesses smaller than 5 cm [",
"    <a class=\"abstract\" href=\"UTD.htm?4/7/4216/abstract/9,10\">",
"     9,10",
"    </a>",
"    ]. This was illustrated in a randomized trial of 166 patients with uncomplicated skin abscesses at risk for community-associated MRSA (CA-MRSA) who were managed with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?36/37/37462?source=see_link\">",
"     cephalexin",
"    </a>",
"    or placebo following incision and drainage of skin and soft tissue abscesses; the cure rates were similar in the two groups (84 and 90 percent, respectively) [",
"    <a class=\"abstract\" href=\"UTD.htm?4/7/4216/abstract/10\">",
"     10",
"    </a>",
"    ]. Among the isolates tested, 88 percent were MRSA; because cephalexin does not have activity against MRSA, the cephalexin arm was also a functional placebo arm in this group. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/46/5865?source=see_link\">",
"     \"Technique of incision and drainage for skin abscess\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with larger abscesses",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    systemic signs of infection should be managed with incision and drainage plus antimicrobial therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?4/7/4216/abstract/9\">",
"     9",
"    </a>",
"    ]. Important considerations in antibiotic selection include baseline susceptibility testing prior to antibiotic administration and individual patient circumstances including the type of infection, underlying comorbidities, and other concurrent medications [",
"    <a class=\"abstract\" href=\"UTD.htm?4/7/4216/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Oral therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The optimal oral antibiotic therapy for empiric treatment of skin and soft tissue infection when MRSA is known or suspected is unclear [",
"    <a class=\"abstract\" href=\"UTD.htm?4/7/4216/abstract/12\">",
"     12",
"    </a>",
"    ]. Reasonable antibiotics for treatment of MRSA include",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/21/33104?source=see_link\">",
"     clindamycin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/58/5034?source=see_link\">",
"     trimethoprim-sulfamethoxazole",
"    </a>",
"    , tetracyclines (such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/41/2714?source=see_link\">",
"     doxycycline",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?3/10/3240?source=see_link\">",
"     minocycline",
"    </a>",
"    ) and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/3/14393?source=see_link\">",
"     linezolid",
"    </a>",
"    (",
"    <a class=\"graphic graphic_table graphicRef64178 \" href=\"UTD.htm?9/57/10140\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?4/7/4216/abstract/13\">",
"     13",
"    </a>",
"    ]. Use of the older agents is supported by susceptibility testing and clinical experience, but their efficacy for treatment of skin and soft tissue infections due to MRSA has not been rigorously evaluated or compared in clinical trials [",
"    <a class=\"abstract\" href=\"UTD.htm?4/7/4216/abstract/14\">",
"     14",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/33/12825?source=see_link&amp;anchor=H8#H8\">",
"     \"Cellulitis and erysipelas\", section on 'Antibiotics'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/51/43831?source=see_link&amp;anchor=H11#H11\">",
"     \"Skin abscesses, furuncles, and carbuncles\", section on 'Antibiotic selection'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H703176\">",
"    <span class=\"h3\">",
"     Antibiotic agents",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H703095\">",
"    <span class=\"h4\">",
"     Clindamycin",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/21/33104?source=see_link\">",
"     Clindamycin",
"    </a>",
"    (300 to 450 mg every six to eight hours) has good activity against MRSA and is also capable of inhibiting bacterial production of toxins including Panton-Valentine leukocidin and other virulence factors, though is bacteriostatic and therefore should not be used for endovascular infections [",
"    <a class=\"abstract\" href=\"UTD.htm?4/7/4216/abstract/15\">",
"     15",
"    </a>",
"    ]. It has excellent tissue penetration, particularly into bone and abscesses [",
"    <a class=\"abstract\" href=\"UTD.htm?4/7/4216/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Careful monitoring of local",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/21/33104?source=see_link\">",
"     clindamycin",
"    </a>",
"    resistance rates is important; some advocate avoiding empiric clindamycin therapy when local MRSA resistance rates to clindamycin exceed 10 to 15 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?4/7/4216/abstract/12\">",
"     12",
"    </a>",
"    ]. In addition, isolates that appear susceptible to clindamycin and resistant to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/29/36304?source=see_link\">",
"     erythromycin",
"    </a>",
"    by standard susceptibility testing techniques may be capable of inducing resistance to clindamycin in the presence of the drug [",
"    <a class=\"abstract\" href=\"UTD.htm?4/7/4216/abstract/17\">",
"     17",
"    </a>",
"    ]. Clinicians should confer with their microbiology laboratory to request evaluation of such isolates for inducible clindamycin resistance with D testing prior to treatment with clindamycin [",
"    <a class=\"abstract\" href=\"UTD.htm?4/7/4216/abstract/18,19\">",
"     18,19",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/5/17495?source=see_link&amp;anchor=H10#H10\">",
"     \"Overview of antibacterial susceptibility testing\", section on 'D test'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H703141\">",
"    <span class=\"h4\">",
"     Trimethoprim-sulfamethoxazole",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/58/5034?source=see_link\">",
"     Trimethoprim-sulfamethoxazole",
"    </a>",
"    (one double-strength tablet twice daily) has been suggested for treatment of skin and soft tissue infections due to MRSA [",
"    <a class=\"abstract\" href=\"UTD.htm?4/7/4216/abstract/20\">",
"     20",
"    </a>",
"    ]; data for its efficacy are limited [",
"    <a class=\"abstract\" href=\"UTD.htm?4/7/4216/abstract/20-25\">",
"     20-25",
"    </a>",
"    ].",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/36/26182?source=see_link\">",
"     Trimethoprim",
"    </a>",
"    -sulfamethoxazole is a reasonable antibiotic choice in the setting of MRSA with known susceptibility to the drug, although it is not advisable for empiric management of soft tissue infections that may be due to group A streptococci [",
"    <a class=\"abstract\" href=\"UTD.htm?4/7/4216/abstract/26\">",
"     26",
"    </a>",
"    ]. In such cases, some favor combination therapy using a beta-lactam antibiotic with activity against streptococci together with trimethoprim-sulfamethoxazole for empiric MRSA coverage (",
"    <a class=\"graphic graphic_table graphicRef76937 \" href=\"UTD.htm?31/58/32684\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?4/7/4216/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There is a theoretic concern that clinical failure with this agent may occur due to thymidine released from damaged host tissues, which may bypass the metabolic blockades of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/36/26182?source=see_link\">",
"     trimethoprim",
"    </a>",
"    and sulfamethoxazole by acting downstream of their target enzymes in the folate synthesis pathway [",
"    <a class=\"abstract\" href=\"UTD.htm?4/7/4216/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H703148\">",
"    <span class=\"h4\">",
"     Tetracyclines",
"    </span>",
"    &nbsp;&mdash;&nbsp;A long-acting tetracycline (such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/41/2714?source=see_link\">",
"     doxycycline",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?3/10/3240?source=see_link\">",
"     minocycline",
"    </a>",
"    ) is a reasonable antibiotic choice in the setting of MRSA with known susceptibility to this agent, although it is not advisable for empiric management of soft tissue infections that may be due to group A streptococci [",
"    <a class=\"abstract\" href=\"UTD.htm?4/7/4216/abstract/26\">",
"     26",
"    </a>",
"    ]. Data on the efficacy of tetracyclines for treatment of skin and soft tissue infections due to MRSA are limited to observational and retrospective reports [",
"    <a class=\"abstract\" href=\"UTD.htm?4/7/4216/abstract/21-24\">",
"     21-24",
"    </a>",
"    ]. In such cases, some favor combination therapy using a beta-lactam antibiotic with activity against streptococci together with a tetracycline for empiric MRSA coverage (",
"    <a class=\"graphic graphic_table graphicRef76937 \" href=\"UTD.htm?31/58/32684\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?4/7/4216/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H703155\">",
"    <span class=\"h4\">",
"     Linezolid or tedizolid",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/3/14393?source=see_link\">",
"     Linezolid",
"    </a>",
"    has activity against both MRSA and streptococci and has been shown to be as effective as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    for the treatment of skin and soft tissue infection [",
"    <a class=\"abstract\" href=\"UTD.htm?4/7/4216/abstract/28\">",
"     28",
"    </a>",
"    ]. Its use is limited by cost, toxicity, and potential for resistance. It should be reserved for those who do not respond to or cannot tolerate an older agent. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/48/21258?source=see_link&amp;anchor=H17417169#H17417169\">",
"     \"Treatment of invasive methicillin-resistant Staphylococcus aureus infections in adults\", section on 'Linezolid'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Tedizolid is a novel oxazolidinone drug that has been shown to be noninferior to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/3/14393?source=see_link\">",
"     linezolid",
"    </a>",
"    for treatment of acute bacterial skin and skin structure infections in early clinical response (48 to 72 hours after initiating therapy) [",
"    <a class=\"abstract\" href=\"UTD.htm?4/7/4216/abstract/29\">",
"     29",
"    </a>",
"    ]. Among 667 adults randomized to receive tedizolid (200 mg once daily for 6 days) or linezolid (600 mg every 12 hours for 10 days), early response rates were 79.5 and 79.4 percent, respectively; sustained treatment response rates (day 11) were 69.3 and 71.9 percent, respectively. S. aureus was isolated in more than 80 percent of patients with a positive culture; MRSA was isolated from more than 40 percent of positive cultures. The safety profiles, including hematologic toxicities, were comparable between the groups. Thus far, tedizolid is not available for use in the United States and has not received FDA approval.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H703162\">",
"    <span class=\"h4\">",
"     Fluoroquinolones",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fluoroquinolones should NOT be used to treat skin and soft tissue infections due to MRSA; resistance to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/45/35536?source=see_link\">",
"     ciprofloxacin",
"    </a>",
"    may develop during therapy, and widespread MRSA fluoroquinolone resistance is already prevalent in many regions [",
"    <a class=\"abstract\" href=\"UTD.htm?4/7/4216/abstract/21,30\">",
"     21,30",
"    </a>",
"    ]. There is also concern that resistance may emerge during therapy, even for fluoroquinolones with enhanced antistaphylococcal activity such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/46/33504?source=see_link\">",
"     levofloxacin",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/51/33584?source=see_link\">",
"     moxifloxacin",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?4/7/4216/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h3\">",
"     Follow-up",
"    </span>",
"    &nbsp;&mdash;&nbsp;Repeat evaluation after 24 to 48 hours of outpatient empiric oral antibiotic therapy is prudent to verify clinical response [",
"    <a class=\"abstract\" href=\"UTD.htm?4/7/4216/abstract/3\">",
"     3",
"    </a>",
"    ]. The appropriate duration of therapy is one to two weeks; the clinical response to therapy should guide antibiotic duration. Lack of response may be due to infection with resistant pathogens or a deeper, more serious infection than previously realized.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Parenteral therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Parenteral therapy should be considered for patients with extensive soft tissue involvement, fever or other signs of systemic illness, or patients with diabetes or other immunodeficiency [",
"    <a class=\"abstract\" href=\"UTD.htm?4/7/4216/abstract/12\">",
"     12",
"    </a>",
"    ]. Such patients should also be evaluated for evidence of invasive disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/53/8026?source=see_link\">",
"     \"Epidemiology of methicillin-resistant Staphylococcus aureus infection in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/48/21258?source=see_link\">",
"     \"Treatment of invasive methicillin-resistant Staphylococcus aureus infections in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/43/24249?source=see_link\">",
"     \"Treatment of Staphylococcus aureus bacteremia in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/1/26649?source=see_link\">",
"     \"Complications of Staphylococcus aureus bacteremia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"     Vancomycin",
"    </a>",
"    remains the antibiotic of choice for treatment of invasive MRSA skin and soft tissue infection, although there is increasing concern regarding the rise in S. aureus MICs to this antibiotic [",
"    <a class=\"abstract\" href=\"UTD.htm?4/7/4216/abstract/31\">",
"     31",
"    </a>",
"    ]. Dosing is 30",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per 24 hours in two divided doses, not to exceed 2 g per 24 hours unless serum concentrations are inappropriately low. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/47/15096?source=see_link\">",
"     \"Vancomycin dosing and serum concentration monitoring in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    For patients who fail to respond or cannot tolerate",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    , the optimal alternative parenteral agent is not known (",
"    <a class=\"graphic graphic_table graphicRef57196 \" href=\"UTD.htm?39/12/40139\">",
"     table 3",
"    </a>",
"    ). Among the alternative agents,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/3/14393?source=see_link\">",
"     linezolid",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?20/10/20646?source=see_link\">",
"     daptomycin",
"    </a>",
"    (4",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    once daily),",
"    <a class=\"drug drug_general\" href=\"UTD.htm?26/42/27301?source=see_link\">",
"     telavancin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/33/4628?source=see_link\">",
"     ceftaroline",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?33/17/34068?source=see_link\">",
"     quinupristin-dalfopristin",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/7/40053?source=see_link\">",
"     tigecycline",
"    </a>",
"    all have FDA approval for treatment of skin and soft tissue infections. If continued outpatient antibiotic therapy is expected, options are outlined in the table (",
"    <a class=\"graphic graphic_table graphicRef64178 \" href=\"UTD.htm?9/57/10140\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?4/7/4216/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In September 2010, the FDA issued a safety announcement regarding increased mortality risk associated with the use of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/7/40053?source=see_link\">",
"     tigecycline",
"    </a>",
"    compared with that of other drugs [",
"    <a class=\"abstract\" href=\"UTD.htm?4/7/4216/abstract/32\">",
"     32",
"    </a>",
"    ]. The increased risk was seen most clearly in patients treated for hospital-acquired pneumonia but was also seen in patients with cSSSI, complicated intraabdominal infections, and diabetic foot infections.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?26/42/27301?source=see_link\">",
"     Telavancin",
"    </a>",
"    (10",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    every 24 hours) has been found to be noninferior to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    for treatment of complicated skin and skin-structure infections in clinical studies [",
"    <a class=\"abstract\" href=\"UTD.htm?4/7/4216/abstract/33\">",
"     33",
"    </a>",
"    ]. However, it has a higher rate of toxicity (including taste disturbance, nausea, vomiting, and renal dysfunction) and substantially higher cost.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/33/4628?source=see_link\">",
"     Ceftaroline",
"    </a>",
"    has been found to be noninferior to vancomycin plus",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/25/43414?source=see_link\">",
"     aztreonam",
"    </a>",
"    for treatment of complicated skin and skin-structure infection; it has a side effect profile similar to other cephalosporins. Use of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?33/17/34068?source=see_link\">",
"     quinupristin-dalfopristin",
"    </a>",
"    is limited by adverse effects [",
"    <a class=\"abstract\" href=\"UTD.htm?4/7/4216/abstract/34\">",
"     34",
"    </a>",
"    ]. These drugs are discussed further separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/48/21258?source=see_link\">",
"     \"Treatment of invasive methicillin-resistant Staphylococcus aureus infections in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Among the older agents, data on parenteral use for treatment of MRSA are limited. Parenteral",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/21/33104?source=see_link\">",
"     clindamycin",
"    </a>",
"    may be given in regions where the likelihood is resistance is low [",
"    <a class=\"abstract\" href=\"UTD.htm?4/7/4216/abstract/12\">",
"     12",
"    </a>",
"    ]. Parenteral",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/58/5034?source=see_link\">",
"     trimethoprim-sulfamethoxazole",
"    </a>",
"    was less effective than",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    in a randomized trial of intravenous drug users with serious S. aureus infections [",
"    <a class=\"abstract\" href=\"UTD.htm?4/7/4216/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The appropriate duration of therapy is one to two weeks; clinical response to therapy may guide antibiotic duration.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6873619\">",
"    <span class=\"h1\">",
"     PREVENTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Issues related to prevention of MRSA infection are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/59/17338?source=see_link&amp;anchor=H9#H9\">",
"     \"Prevention and control of methicillin-resistant Staphylococcus aureus in adults\", section on 'Decolonization'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?30/47/31473?source=see_link\">",
"       \"Patient information: Methicillin-resistant Staphylococcus aureus (MRSA) (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?22/4/22595?source=see_link\">",
"       \"Patient information: Methicillin-resistant Staphylococcus aureus (MRSA) (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients with skin and soft tissue infections amenable to debridement should undergo incision and drainage. Culture and susceptibility testing of the drainage material should be performed, given variable antibiotic susceptibility in different geographic regions. Debridement alone may be sufficient for abscesses smaller than 5 cm.",
"     </li>",
"     <li>",
"      Patients with larger areas of infection",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      systemic signs of infection should be managed with antimicrobial therapy. Susceptibility testing should guide antibiotic selection. It is appropriate for empiric antibiotic therapy to include activity against MRSA.",
"     </li>",
"     <li>",
"      For the outpatient management of possible or proven MRSA infection, we suggest oral antibiotic therapy with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/21/33104?source=see_link\">",
"       clindamycin",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?4/58/5034?source=see_link\">",
"       trimethoprim-sulfamethoxazole",
"      </a>",
"      , or a long-acting tetracycline such as",
"      <a class=\"drug drug_general\" href=\"UTD.htm?3/10/3240?source=see_link\">",
"       minocycline",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?2/41/2714?source=see_link\">",
"       doxycycline",
"      </a>",
"      &nbsp;(",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ).",
"      <a class=\"drug drug_general\" href=\"UTD.htm?14/3/14393?source=see_link\">",
"       Linezolid",
"      </a>",
"      is an acceptable alternative agent; its use is limited by cost and potential toxicity. Appropriate dosing for these agents is as outlined in the Table (",
"      <a class=\"graphic graphic_table graphicRef64178 \" href=\"UTD.htm?9/57/10140\">",
"       table 1",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Parenteral therapy should be considered for patients with extensive soft tissue involvement, fever, or other signs of systemic illness, or patients with diabetes or other immunodeficiency. We suggest parenteral antibiotic therapy with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"       vancomycin",
"      </a>",
"      (30",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per 24 hours in two divided doses, not to exceed 2 g per 24 hours unless serum concentrations are inappropriately low) (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?14/47/15096?source=see_link\">",
"       \"Vancomycin dosing and serum concentration monitoring in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      For patients who fail to respond or cannot tolerate",
"      <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"       vancomycin",
"      </a>",
"      , we suggest",
"      <a class=\"drug drug_general\" href=\"UTD.htm?14/3/14393?source=see_link\">",
"       linezolid",
"      </a>",
"      (600 mg every 12 hours) or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?20/10/20646?source=see_link\">",
"       daptomycin",
"      </a>",
"      (4",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      once daily) (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      The duration of therapy is usually one to two weeks; the clinical response to therapy may guide antibiotic duration. Treatment may be switched from parenteral to oral therapy with clinical improvement.",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/7/4216/abstract/1\">",
"      Karchmer AW. Staphylococcus aureus and vancomycin: the sequel. Ann Intern Med 1991; 115:739.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/7/4216/abstract/2\">",
"      Lowy FD. Staphylococcus aureus infections. N Engl J Med 1998; 339:520.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/7/4216/abstract/3\">",
"      Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis 2005; 41:1373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/7/4216/abstract/4\">",
"      Chambers HF. The changing epidemiology of Staphylococcus aureus? Emerg Infect Dis 2001; 7:178.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/7/4216/abstract/5\">",
"      Charlebois ED, Perdreau-Remington F, Kreiswirth B, et al. Origins of community strains of methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2004; 39:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/7/4216/abstract/6\">",
"      Miller LG, Perdreau-Remington F, Bayer AS, et al. Clinical and epidemiologic characteristics cannot distinguish community-associated methicillin-resistant Staphylococcus aureus infection from methicillin-susceptible S. aureus infection: a prospective investigation. Clin Infect Dis 2007; 44:471.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/7/4216/abstract/7\">",
"      von Eiff C, Becker K, Machka K, et al. Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group. N Engl J Med 2001; 344:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/7/4216/abstract/8\">",
"      Miller LG, Quan C, Shay A, et al. A prospective investigation of outcomes after hospital discharge for endemic, community-acquired methicillin-resistant and -susceptible Staphylococcus aureus skin infection. Clin Infect Dis 2007; 44:483.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/7/4216/abstract/9\">",
"      Lee MC, Rios AM, Aten MF, et al. Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin-resistant Staphylococcus aureus. Pediatr Infect Dis J 2004; 23:123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/7/4216/abstract/10\">",
"      Rajendran PM, Young D, Maurer T, et al. Randomized, double-blind, placebo-controlled trial of cephalexin for treatment of uncomplicated skin abscesses in a population at risk for community-acquired methicillin-resistant Staphylococcus aureus infection. Antimicrob Agents Chemother 2007; 51:4044.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/7/4216/abstract/11\">",
"      Ruhe JJ, Smith N, Bradsher RW, Menon A. Community-onset methicillin-resistant Staphylococcus aureus skin and soft-tissue infections: impact of antimicrobial therapy on outcome. Clin Infect Dis 2007; 44:777.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/7/4216/abstract/12\">",
"      Daum RS. Clinical practice. Skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus. N Engl J Med 2007; 357:380.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/7/4216/abstract/13\">",
"      Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis 2011; 52:e18.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/7/4216/abstract/14\">",
"      Moellering RC Jr. Current treatment options for community-acquired methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis 2008; 46:1032.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/7/4216/abstract/15\">",
"      Mart&iacute;nez-Aguilar G, Hammerman WA, Mason EO Jr, Kaplan SL. Clindamycin treatment of invasive infections caused by community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus in children. Pediatr Infect Dis J 2003; 22:593.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/7/4216/abstract/16\">",
"      Panzer JD, Brown DC, Epstein WL, et al. Clindamycin levels in various body tissues and fluids. J Clin Pharmacol New Drugs 1972; 12:259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/7/4216/abstract/17\">",
"      Siberry GK, Tekle T, Carroll K, Dick J. Failure of clindamycin treatment of methicillin-resistant Staphylococcus aureus expressing inducible clindamycin resistance in vitro. Clin Infect Dis 2003; 37:1257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/7/4216/abstract/18\">",
"      Panagea S, Perry JD, Gould FK. Should clindamycin be used as treatment of patients with infections caused by erythromycin-resistant staphylococci? J Antimicrob Chemother 1999; 44:581.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/7/4216/abstract/19\">",
"      Frank AL, Marcinak JF, Mangat PD, et al. Clindamycin treatment of methicillin-resistant Staphylococcus aureus infections in children. Pediatr Infect Dis J 2002; 21:530.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/7/4216/abstract/20\">",
"      Cadena J, Nair S, Henao-Martinez AF, et al. Dose of trimethoprim-sulfamethoxazole to treat skin and skin structure infections caused by methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2011; 55:5430.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/7/4216/abstract/21\">",
"      Moran GJ, Krishnadasan A, Gorwitz RJ, et al. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 2006; 355:666.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/7/4216/abstract/22\">",
"      Szumowski JD, Cohen DE, Kanaya F, Mayer KH. Treatment and outcomes of infections by methicillin-resistant Staphylococcus aureus at an ambulatory clinic. Antimicrob Agents Chemother 2007; 51:423.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/7/4216/abstract/23\">",
"      Iyer S, Jones DH. Community-acquired methicillin-resistant Staphylococcus aureus skin infection: a retrospective analysis of clinical presentation and treatment of a local outbreak. J Am Acad Dermatol 2004; 50:854.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/7/4216/abstract/24\">",
"      Ruhe JJ, Monson T, Bradsher RW, Menon A. Use of long-acting tetracyclines for methicillin-resistant Staphylococcus aureus infections: case series and review of the literature. Clin Infect Dis 2005; 40:1429.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/7/4216/abstract/25\">",
"      Kaka AS, Rueda AM, Shelburne SA 3rd, et al. Bactericidal activity of orally available agents against methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother 2006; 58:680.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/7/4216/abstract/26\">",
"      Swartz MN. Clinical practice. Cellulitis. N Engl J Med 2004; 350:904.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/7/4216/abstract/27\">",
"      Proctor RA. Role of folate antagonists in the treatment of methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis 2008; 46:584.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/7/4216/abstract/28\">",
"      Stevens DL, Herr D, Lampiris H, et al. Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections. Clin Infect Dis 2002; 34:1481.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/7/4216/abstract/29\">",
"      Prokocimer P, De Anda C, Fang E, et al. Tedizolid phosphate vs linezolid for treatment of acute bacterial skin and skin structure infections: the ESTABLISH-1 randomized trial. JAMA 2013; 309:559.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/7/4216/abstract/30\">",
"      Trucksis M, Hooper DC, Wolfson JS. Emerging resistance to fluoroquinolones in staphylococci: an alert. Ann Intern Med 1991; 114:424.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/7/4216/abstract/31\">",
"      Choice of antibacterial drugs. Treat Guidel Med Lett 2007; 5:33.",
"     </a>",
"    </li>",
"    <li>",
"     file://www.fda.gov/Drugs/DrugSafety/ucm224370.htm (Accessed September 2, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/7/4216/abstract/33\">",
"      Stryjewski ME, Graham DR, Wilson SE, et al. Telavancin versus vancomycin for the treatment of complicated skin and skin-structure infections caused by gram-positive organisms. Clin Infect Dis 2008; 46:1683.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/7/4216/abstract/34\">",
"      Corey GR, Wilcox M, Talbot GH, et al. Integrated analysis of CANVAS 1 and 2: phase 3, multicenter, randomized, double-blind studies to evaluate the safety and efficacy of ceftaroline versus vancomycin plus aztreonam in complicated skin and skin-structure infection. Clin Infect Dis 2010; 51:641.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/7/4216/abstract/35\">",
"      Markowitz N, Quinn EL, Saravolatz LD. Trimethoprim-sulfamethoxazole compared with vancomycin for the treatment of Staphylococcus aureus infection. Ann Intern Med 1992; 117:390.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3176 Version 19.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-125.39.66.147-8BB6C55152-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_7_4216=[""].join("\n");
var outline_f4_7_4216=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H7\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      APPROACH TO TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Oral therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H703176\">",
"      - Antibiotic agents",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H703095\">",
"      Clindamycin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H703141\">",
"      Trimethoprim-sulfamethoxazole",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H703148\">",
"      Tetracyclines",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H703155\">",
"      Linezolid or tedizolid",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H703162\">",
"      Fluoroquinolones",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      - Follow-up",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Parenteral therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6873619\">",
"      PREVENTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/3176\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/3176|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?9/57/10140\" title=\"table 1\">",
"      Oral antibiotics for infections due to MRSA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?31/58/32684\" title=\"table 2\">",
"      Empiric oral treatment for MRSA and beta-hemolytic streptococci",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?39/12/40139\" title=\"table 3\">",
"      Parenteral antibiotics for infections due to MRSA",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/33/12825?source=related_link\">",
"      Cellulitis and erysipelas",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/1/26649?source=related_link\">",
"      Complications of Staphylococcus aureus bacteremia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/53/8026?source=related_link\">",
"      Epidemiology of methicillin-resistant Staphylococcus aureus infection in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/55/22387?source=related_link\">",
"      Folliculitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/21/21846?source=related_link\">",
"      Impetigo",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/13/15575?source=related_link\">",
"      Microbiology of methicillin-resistant Staphylococcus aureus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/5/17495?source=related_link\">",
"      Overview of antibacterial susceptibility testing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?22/4/22595?source=related_link\">",
"      Patient information: Methicillin-resistant Staphylococcus aureus (MRSA) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?30/47/31473?source=related_link\">",
"      Patient information: Methicillin-resistant Staphylococcus aureus (MRSA) (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/59/17338?source=related_link\">",
"      Prevention and control of methicillin-resistant Staphylococcus aureus in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/51/43831?source=related_link\">",
"      Skin abscesses, furuncles, and carbuncles",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/46/5865?source=related_link\">",
"      Technique of incision and drainage for skin abscess",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/43/24249?source=related_link\">",
"      Treatment of Staphylococcus aureus bacteremia in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/48/21258?source=related_link\">",
"      Treatment of invasive methicillin-resistant Staphylococcus aureus infections in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/47/15096?source=related_link\">",
"      Vancomycin dosing and serum concentration monitoring in adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f4_7_4217="Plantar foot anatomy";
var content_f4_7_4217=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F82236%7EPC%2F52461&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F82236%7EPC%2F52461&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Plantar foot anatomy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 430px; height: 507px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The path of plantar arteries (red) and nerves (green) to the toes is shown. Each digit is innervated by four digital nerves; the dorsal arteries and nerves are not shown in this figure. In order to achieve a complete anesthetic effect, it is necessary to block all four nerves. For a complete block of the great toe, there are additional branches that come up the dorsal aspect of the great toe that can be missed if anesthetic is only injected laterally and medially.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Dorsal foot anatomy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 411px; height: 541px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The path of dorsal arteries (red) and nerves (green) to the toes is shown. Each digit is innervated by four digital nerves; the plantar arteries and nerves are not shown in this figure. In order to achieve a complete anesthetic effect, it is necessary to block all four nerves. For a complete block of the great toe, there are additional branches that come up the dorsal aspect of the great toe that can be missed if anesthetic is only injected laterally and medially.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_7_4217=[""].join("\n");
var outline_f4_7_4217=null;
var title_f4_7_4218="Childhood immunization schedule 0 to 6 yrs";
var content_f4_7_4218=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F82617%7EPEDS%2F58209&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F82617%7EPEDS%2F58209&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 676px\">",
"   <div class=\"ttl\">",
"    Recommended immunization schedule for persons aged 0 through 6 years - United States, 2013 (for those who fall behind or start late, see the catch-up schedule)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 656px; height: 816px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This schedule includes recommendations in effect as of January 1, 2013. Any dose not administered at the recommended age should be administered at a subsequent visit, when indicated and feasible. The use of a combination vaccine generally is preferred over separate injections of its equivalent component vaccines. Vaccination providers should consult the relevant Advisory Committee on Immunization Practices (ACIP) statement for detailed recommendations, available online at",
"    <a href=\"file://www.cdc.gov/vaccines/pubs/acip-list.htm\" target=\"_blank\">",
"     www.cdc.gov/vaccines/pubs/acip-list.htm",
"    </a>",
"    . Clinically significant adverse events that follow vaccination should be reported to the Vaccine Adverse Event Reporting System (VAERS) at",
"    <a href=\"file://www.vaers.hhs.gov\" target=\"_blank\">",
"     www.vaers.hhs.gov",
"    </a>",
"    or by telephone, 800-822-7967. Suspected cases of vaccine-preventable diseases should be reported to the state or local health department. Additional information including precautions and contraindications for vaccination is available from the CDC online at",
"    <a href=\"file://www.cdc.gov/vaccines\" target=\"_blank\">",
"     www.cdc.gov/vaccines",
"    </a>",
"    or by telephone, 800-232-4636. This schedule is approved by the ACIP, the American Academy of Pediatrics, the American Academy of Family Physicians, and the American College of Obstetricians and Gynecologists.",
"    <div class=\"footnotes\">",
"     *",
"     <strong>",
"      Hepatitis B (HepB) vaccine:",
"     </strong>",
"     <em>",
"      (Minimum age: birth)",
"     </em>",
"     <br>",
"      -",
"      <strong>",
"       At birth:",
"      </strong>",
"      : Administer monovalent HepB vaccine to all newborns before hospital discharge. For infants born to hepatitis B surface antigen (HBsAg)-positive mothers, administer HepB vaccine and 0.5 mL of hepatitis B immune globulin (HBIG) within 12 hours of birth. These infants should be tested for HBsAg and antibody to HBsAg (anti-HBs) 1 to 2 months after completion of the HepB series, at age 9 through 18 months (preferably at the next well-child visit). If mother's HBsAg status is unknown, within 12 hours of birth administer HepB vaccine to all infants regardless of birth weight. For infants weighing &lt;2000 grams, administer HBIG in addition to HepB within 12 hours of birth. Determine mother's HBsAg status as soon as possible and, if she is HBsAg-positive, also administer HBIG for infants weighing &ge;2000 grams (no later than age 1 week).",
"      <br>",
"       -",
"       <strong>",
"        Doses following the birth dose:",
"       </strong>",
"       The second dose should be administered at age 1 or 2 months. Monovalent HepB vaccine should be used for doses administered before age 6 weeks. Infants who did not receive a birth dose should receive 3 doses of a HepB-containing vaccine on a schedule of 0, 1 to 2 months, and 6 months starting as soon as feasible. The minimum interval between dose 1 and dose 2 is 4 weeks and between dose 2 and 3 is 8 weeks. The final (third or fourth) dose in the HepB vaccine series should be administered no earlier than age 24 weeks, and at least 16 weeks after the first dose. Administration of a total of 4 doses of HepB vaccine is recommended when a combination vaccine containing HepB is administered after the birth dose.",
"       <br>",
"        <font class=\"bullet\">",
"         &bull;",
"        </font>",
"        <strong>",
"         Rotavirus (RV) vaccine:",
"        </strong>",
"        <em>",
"         (Minimum age: 6 weeks for both RV1 [Rotarix] and RV5 [RotaTeq])",
"        </em>",
"        Administer a series of RV vaccine to all infants as follows: 1) If RV1 is used, administer a 2-dose series at 2 and 4 months of age. 2) If RV5 is used, administer a 3-dose series at ages 2, 4, and 6 months. 3) If any dose in series was RV5 or vaccine product is unknown for any dose in the series, a total of 3 doses of RV vaccine should be administered.",
"        <br>",
"         &Delta;",
"         <strong>",
"          Diphtheria and tetanus toxoids and acellular pertussis (DTaP) vaccine:",
"         </strong>",
"         <em>",
"          (Minimum age: 6 weeks)",
"         </em>",
"         Administer a 5-dose series of DTaP vaccine at ages 2, 4, 6, 15 to 18 months, and 4 through 6 years. The fourth dose may be administered as early as age 12 months, provided at least 6 months have elapsed since the third dose.",
"         <br>",
"          <font class=\"lozenge\">",
"           &loz;",
"          </font>",
"          <strong>",
"           <em>",
"            Haemophilus influenzae",
"           </em>",
"           type b (Hib) conjugate vaccine:",
"          </strong>",
"          <em>",
"           (Minimum age: 6 weeks)",
"          </em>",
"          Administer a Hib vaccine primary series and a booster dose to all infants. The primary series doses should be administered at 2, 4, and 6 months of age; however, if PRP-OMP (PedvaxHib or Comvax) is administered at 2 and 4 months of age, a dose at age 6 months is not indicated. One booster dose should be administered at age 12 through 15 months. Hiberix (PRP-T) should only be used for the booster (final) dose in children aged 12 months through 4 years, who have received at least 1 dose of Hib.",
"          <br>",
"           <strong>",
"            Vaccination of persons with high-risk conditions:",
"           </strong>",
"           Hib vaccine is not routinely recommended for patients older than 5 years of age. However 1dose of Hib vaccine should be administered to unvaccinated or partially vaccinated persons aged 5 years or older who have leukemia, malignant neoplasms, anatomic or functional asplenia (including sickle cell disease), human immunodeficiency virus (HIV) infection, or other immunocompromising conditions.",
"           <br>",
"            &sect;",
"            <strong>",
"             Pneumococcal conjugate vaccine (PCV):",
"            </strong>",
"            <em>",
"             (Minimum age: 6 weeks)",
"            </em>",
"            Administer a series of PCV13 vaccine at ages 2, 4, 6 months with a booster at age 12 through 15 months. For children aged 14 through 59 months who have received an age-appropriate series of 7-valent PCV (PCV7), administer a single supplemental dose of 13-valent PCV (PCV13).",
"            <br>",
"             <strong>",
"              Vaccination of persons with high-risk conditions:",
"             </strong>",
"             For children aged 24 through 71 months with high risk conditions (listed below), administer 1 dose of PCV13 if 3 doses of PCV were received previously, or administer 2 doses of PCV13 at least 8 weeks apart if fewer than 3 doses of PCV were received previously. Children with high risk conditions aged 2 years or older also should receive pneumococcal polysaccharide vaccine (PPSV23) at least 8 weeks after the last dose of PCV. A single dose of PCV13 may be administered to previously unvaccinated children aged 6 through 18 years who have anatomic or functional asplenia (including sickle cell disease), HIV infection or an immunocompromising condition, cochlear implant or cerebrospinal fluid leak. See MMWR 2010; 59 (No. RR-11), available at",
"             <a href=\"file://www.cdc.gov/mmwr/pdf/rr/rr5911.pdf\" target=\"_blank\">",
"              www.cdc.gov/mmwr/pdf/rr/rr5911.pdf",
"             </a>",
"             .",
"             <br>",
"              <strong>",
"               High risk conditions:",
"              </strong>",
"              1) Immunocompetent children with chronic heart disease (particularly cyanotic congenital heart disease and cardiac failure); chronic lung disease (including asthma if treated with high-dose oral corticosteroid therapy), diabetes mellitus; cerebrospinal fluid leaks; or cochlear implant. 2) Children with anatomic or functional asplenia (including sickle cell disease and other hemoglobinopathies, congenital or acquired asplenia, or splenic dysfunction). 3) Children with immunocompromising conditions: HIV infection, chronic renal failure and nephrotic syndrome, diseases associated with treatment with immunosuppressive drugs or radiation therapy, including malignant neoplasms, leukemias, lymphomas and Hodgkin disease; or solid organ transplantation, congenital immunodeficiency.",
"              <br>",
"               &yen;",
"               <strong>",
"                Pneumococcal polysaccharide vaccine (PPSV23):",
"               </strong>",
"               <em>",
"                (Minimum age: 2 years)",
"               </em>",
"               Administer PPSV23 at least 8 weeks after the last dose of PCV to children aged 2 years or older with high risk conditions (listed above). A single revaccination with PPSV23 should be administered after 5 years to children with anatomic or functional asplenia (including sickle cell disease) or an immunocompromising condition.",
"               <br>",
"                &Dagger;",
"                <strong>",
"                 Inactivated poliovirus (IPV) vaccine:",
"                </strong>",
"                <em>",
"                 (Minimum age: 6 weeks)",
"                </em>",
"                Administer a series of IPV at ages 2, 4, 6 to 18 months, with a booster at age 4 to 6 years. The final dose in the series should be administered on or after the fourth birthday and at least 6 months after the previous dose.",
"                <br>",
"                 &dagger;",
"                 <strong>",
"                  Influenza vaccine:",
"                 </strong>",
"                 <em>",
"                  (Minimum age: 6 months for inactivated influenza vaccine [IIV]; 2 years for live, attenuated influenza vaccine [LAIV])",
"                 </em>",
"                 Administer influenza vaccine annually to all children beginning at age 6 months. For most healthy, nonpregnant persons aged 2 through 49 years, either LAIV or IIV may be used. However, LAIV should NOT be administered to some persons, including 1) those with asthma, 2) children 2 through 4 years who had wheezing in the past 12 months, or 3) those who have any other underlying medical conditions that predispose them to influenza complications. For all other contraindications to use of LAIV see MMWR 2010; 59 (No. RR-8), available at",
"                 <a href=\"file://www.cdc.gov/mmwr/pdf/rr/rr5908.pdf\" target=\"_blank\">",
"                  www.cdc.gov/mmwr/pdf/rr/rr5908.pdf",
"                 </a>",
"                 . Administer 1 dose to persons aged 9 years and older. For children aged 6 months through 8 years: For the 2012-13 season, administer 2 doses (separated by at least 4 weeks) to children who are receiving influenza vaccine for the first time. For additional guidance, follow dosing guidelines in the 2012 ACIP influenza vaccine recommendations, MMWR 2012; 61:613, available at",
"                 <a href=\"file://www.cdc.gov/mmwr/pdf/wk/mm6132.pdf\" target=\"_blank\">",
"                  www.cdc.gov/mmwr/pdf/wk/mm6132.pdf",
"                 </a>",
"                 . For the 2013-14 season, follow dosing guidelines in the 2013 ACIP influenza vaccine recommendations.",
"                 <br>",
"                  **",
"                  <strong>",
"                   Measles, mumps, and rubella (MMR) vaccine:",
"                  </strong>",
"                  <em>",
"                   (Minimum age: 12 months)",
"                  </em>",
"                  Administer the first dose of MMR vaccine at age 12 through 15 months, and the second dose at age 4 through 6 years. The second dose may be administered before age 4 years, provided at least 4 weeks have elapsed since the first dose. Administer 1 dose of MMR vaccine to infants aged 6 through 11 months before departure from the United States for international travel. These children should be revaccinated with 2 doses of MMR vaccine, the first at age 12 through 15 months (12 months if the child remains in an area where disease risk is high), and the second dose at least 4 weeks later. Administer 2 doses of MMR vaccine to children aged 12 months and older, before departure from the United States for international travel. The first dose should be administered on or after age 12 months and the second dose at least 4 weeks later.",
"                  <br>",
"                   <font class=\"double_bullet\">",
"                    &bull;&bull;",
"                   </font>",
"                   <strong>",
"                    Varicella (VAR) vaccine:",
"                   </strong>",
"                   <em>",
"                    (Minimum age: 12 months)",
"                   </em>",
"                   Administer the first dose of VAR vaccine at age 12 through 15 months, and the second dose at age 4 through 6 years. The second dose may be administered before age 4 years, provided at least 3 months have elapsed since the first dose. If the second dose was administered at least 4 weeks after the first dose, it can be accepted as valid.",
"                   <br>",
"                    &Delta;&Delta;",
"                    <strong>",
"                     Hepatitis A (Hep A) vaccine:",
"                    </strong>",
"                    <em>",
"                     (Minimum age: 12 months)",
"                    </em>",
"                    Initiate the 2-dose HepA vaccine series for children aged 12 through 23 months; separate the 2 doses by 6 to 18 months. Children who have received 1 dose of HepA vaccine before age 24 months should receive a second dose 6 to 18 months after the first dose. For any person aged 2 years and older who has not already received the HepA vaccine series, 2 doses of HepA vaccine separated by 6 to 18 months may be administered if immunity against hepatitis A virus infection is desired.",
"                    <strong>",
"                     Special populations:",
"                    </strong>",
"                    Administer 2 doses of HepA vaccine at least 6 months apart to previously unvaccinated persons who live in areas where vaccination programs target older children, or who are at increased risk for infection.",
"                    <br>",
"                     <font class=\"double_lozenge\">",
"                      &loz;&loz;",
"                     </font>",
"                     <strong>",
"                      Meningococcal conjugate vaccines (MCV):",
"                     </strong>",
"                     <em>",
"                      (Minimum age: 6 weeks for (Menhibrix) HibMenCY, 9 months for Menactra [MCV4-D], 2 years for Menveo [MCV4-CRM])",
"                     </em>",
"                     Vaccination of persons with high-risk conditions: For children younger than 19 months of age with anatomic or functional asplenia (including sickle cell disease), administer an infant series of HibMenCY at 2, 4, 6, and 12 to 15 months. For children aged 2 through 18 months with persistent complement component deficiency, administer either an infant series of HibMenCY at 2, 4, 6, and 12 through 15 months or a 2-dose primary series of MCV4-D starting at 9 months, with at least 8 weeks between doses. For children aged 19 through 23 months with persistent complement component deficiency who have not received a complete series of HibMenCY or MCV4-D, administer 2 primary doses of MCV4-D at least 8 weeks apart. For children aged 24 months and older with persistent complement component deficiency or anatomic or functional asplenia (including sickle cell disease), who have not received a complete series of HibMenCY or MCV4-D, administer 2 primary doses of either MCV4-D or MCV4-CRM. MCV4-D should not be administered to a child with asplenia (including sickle cell disease) until 2 years of age and at least 4 weeks after the completion of all PCV13 doses. See MMWR 2011; 60:1391, available at",
"                     <a href=\"file://www.cdc.gov/mmwr/pdf/wk/mm6040.pdf\" target=\"_blank\">",
"                      www.cdc.gov/mmwr/pdf/wk/mm6040.pdf",
"                     </a>",
"                     . For children aged 9 months and older who are residents of or travelers to countries in the African meningitis belt or to the Hajj, administer an age-appropriate formulation and series of MCV4 for protection against serogroups A and W-135. Prior receipt of HibMenCY is not sufficient for children traveling to the meningitis belt or the Hajj. See MMWR 2011; 60:1391, available at",
"                     <a href=\"file://www.cdc.gov/mmwr/pdf/wk/mm6040.pdf\" target=\"_blank\">",
"                      www.cdc.gov/mmwr/pdf/wk/mm6040.pdf",
"                     </a>",
"                     . For children who are present during outbreaks caused by a vaccine serogroup, administer or complete an age- and formulation-appropriate series of HibMenCY or MCV4. For booster doses among persons with high-risk conditions refer to",
"                     <a href=\"file://www.cdc.gov/vaccines/pubs/acip-list.htm#mening\" target=\"_blank\">",
"                      www.cdc.gov/vaccines/pubs/acip-list.htm#mening",
"                     </a>",
"                     .",
"                    </br>",
"                   </br>",
"                  </br>",
"                 </br>",
"                </br>",
"               </br>",
"              </br>",
"             </br>",
"            </br>",
"           </br>",
"          </br>",
"         </br>",
"        </br>",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from: Akinsanya-Beysolow I, Jenkins R, Meissner HC, Immunization Services Division, National Center for Immunization and Respiratory Diseases, CDC. Advisory Committee on Immunization Practices (ACIP) Recommended Immunization Schedule for Persons Aged 0 Through 18 Years - United States, 2013. MMWR Surveill Summ 2013; 62:2. Available at:",
"     <a href=\"file://www.cdc.gov/vaccines/schedules/downloads/child/0-18yrs-schedule.pdf\" target=\"_blank\">",
"      www.cdc.gov/vaccines/schedules/downloads/child/0-18yrs-schedule.pdf",
"     </a>",
"     (Accessed on February 3, 2013).",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 616px\">",
"   <div class=\"ttl\">",
"    Recommended immunization schedule for persons aged 7 through 18 years - United States, 2013 (for those who fall behind or start late, see the schedule below and the catch-up schedule)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 596px; height: 758px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This schedule includes recommendations in effect as of January 1, 2013. Any dose not administered at the recommended age should be administered at a subsequent visit, when indicated and feasible. The use of a combination vaccine generally is preferred over separate injections of its equivalent component vaccines. Vaccination providers should consult the relevant Advisory Committee on Immunization Practices (ACIP) statement for detailed recommendations, available online at",
"    <a href=\"file://www.cdc.gov/vaccines/pubs/acip-list.htm\" target=\"_blank\">",
"     www.cdc.gov/vaccines/pubs/acip-list.htm",
"    </a>",
"    . Clinically significant adverse events that follow vaccination should be reported to the Vaccine Adverse Event Reporting System (VAERS) at",
"    <a href=\"file://www.vaers.hhs.gov\" target=\"_blank\">",
"     www.vaers.hhs.gov",
"    </a>",
"    or by telephone, 800-822-7967. Suspected cases of vaccine-preventable diseases should be reported to the state or local health department. Additional information including precautions and contraindications for vaccination is available from the CDC online at",
"    <a href=\"file://www.cdc.gov/vaccines\" target=\"_blank\">",
"     www.cdc.gov/vaccines",
"    </a>",
"    or by telephone, 800-232-4636. This schedule is approved by the ACIP, the American Academy of Pediatrics, the American Academy of Family Physicians, and the American College of Obstetricians and Gynecologists.",
"    <div class=\"footnotes\">",
"     *",
"     <strong>",
"      Tetanus and diphtheria toxoids and acellular pertussis (Tdap) vaccine:",
"     </strong>",
"     <em>",
"      (Minimum age: 10 years for Boostrix and 11 years for Adacel)",
"     </em>",
"     Administer 1 dose of Tdap vaccine to all adolescents aged 11 through 12 years. Tdap can be administered regardless of the interval since the last tetanus and diphtheria toxoid-containing vaccine. Administer 1dose of Tdap vaccine to pregnant adolescents during each pregnancy (preferred during 27 through 36 weeks gestation) regardless of number of years from prior Td or Tdap vaccination.",
"     <br/>",
"     <span class=\"bullet\">",
"      &bull;",
"     </span>",
"     <strong>",
"      Human papillomavirus (HPV) vaccines (HPV4 [Gardasil] and HPV2 [Cervarix]):",
"     </strong>",
"     <em>",
"      (Minimum age: 9 years)",
"     </em>",
"     Administer a 3-dose series of HPV vaccine on a schedule of 0, 1 to 2, and 6 months to all adolescents aged 11 to 12 years. Either HPV4 or HPV2 may be used for females, and only HPV4 may be used for males. The vaccine series can be started beginning at age 9 years. Administer the second dose 1 to 2 months after the first dose and the third dose 6 months after the first dose (at least 24 weeks after the first dose).",
"     <br/>",
"     &Delta;",
"     <strong>",
"      Meningococcal conjugate vaccines (MCV):",
"     </strong>",
"     <em>",
"      (Minimum age: 9 months for Menactra [MCV4-D], 2 years for Menveo [MCV4-CRM])",
"     </em>",
"     Administer MCV4 vaccine at age 11 to 12 years, with a booster dose at age 16 years. Adolescents aged 11 through 18 years with human immunodeficiency virus (HIV) infection should receive a 2-dose primary series of MCV4, with at least 8 weeks between doses. See MMWR 2011; 60:1018, available at:",
"     <a href=\"file://www.cdc.gov/mmwr/pdf/wk/mm6030.pdf\" target=\"_blank\">",
"      www.cdc.gov/mmwr/pdf/wk/mm6030.pdf",
"     </a>",
"     .",
"     <br/>",
"     <strong>",
"      Vaccination of persons with high-risk conditions:",
"     </strong>",
"     For children aged 24 months and older with persistent complement component deficiency or anatomic or functional asplenia (including sickle cell disease), who have not received a complete series of HibMenCY or MCV4-D, administer 2 primary doses of either MCV4-D or MCV4-CRM. MCV4-D should not be administered to a child with asplenia (including sickle cell disease) until at least 4 weeks after the completion of all PCV13 doses. See MMWR 2011; 60:1391, available at",
"     <a href=\"file://www.cdc.gov/mmwr/pdf/wk/mm6040.pdf\" target=\"_blank\">",
"      www.cdc.gov/mmwr/pdf/wk/mm6040.pdf",
"     </a>",
"     . For children aged 9 months and older who are residents of or travelers to countries in the African meningitis belt or to the Hajj, administer an age-appropriate formulation and series of MCV4 for protection against serogroups A and W-135. Prior receipt of HibMenCY is not sufficient for children traveling to the meningitis belt or the Hajj. See MMWR 2011; 60:1391, available at",
"     <a href=\"file://www.cdc.gov/mmwr/pdf/wk/mm6040.pdf\" target=\"_blank\">",
"      www.cdc.gov/mmwr/pdf/wk/mm6040.pdf",
"     </a>",
"     . For children who are present during outbreaks caused by a vaccine serogroup, administer or complete an age- and formulation-appropriate series of MCV4. For booster doses among persons with high-risk conditions refer to",
"     <a href=\"file://www.cdc.gov/vaccines/pubs/acip-list.htm#mening\" target=\"_blank\">",
"      www.cdc.gov/vaccines/pubs/acip-list.htm#mening",
"     </a>",
"     .",
"     <br/>",
"     <span class=\"lozenge\">",
"      &loz;",
"     </span>",
"     <strong>",
"      Influenza vaccines:",
"     </strong>",
"     <em>",
"      (Minimum age: 6 months for inactivated influenza vaccine [IIV], 2 years for live, attenuated influenza vaccine [LAIV])",
"     </em>",
"     Administer influenza vaccine annually to all children beginning at age 6 months. For most healthy, nonpregnant persons aged 2 through 49 years, either LAIV or IIV may be used. However, LAIV should NOT be administered to some persons, including 1) those with asthma, 2) children 2 through 4 years who had wheezing in the past 12 months, or 3) those who have any other underlying medical conditions that predispose them to influenza complications. For all other contraindications to use of LAIV see MMWR 2010; 59 (No. RR-8), available at",
"     <a href=\"file://www.cdc.gov/mmwr/pdf/rr/rr5908.pdf\" target=\"_blank\">",
"      www.cdc.gov/mmwr/pdf/rr/rr5908.pdf",
"     </a>",
"     . Administer 1 dose to persons aged 9 years and older. For children aged 6 months through 8 years: 1) For the 2012-13 season, administer 2 doses (separated by at least 4 weeks) to children who are receiving influenza vaccine for the first time. For additional guidance, follow dosing guidelines in the 2012 ACIP influenza vaccine recommendations, MMWR 2012; 61: 613, available at",
"     <a href=\"file://www.cdc.gov/mmwr/pdf/wk/mm6132.pdf\" target=\"_blank\">",
"      www.cdc.gov/mmwr/pdf/wk/mm6132.pdf",
"     </a>",
"     ; 2) For the 2013-14 season, follow dosing guidelines in the 2013 ACIP influenza vaccine recommendations.",
"     <br/>",
"     &sect;",
"     <strong>",
"      Pneumococcal conjugate vaccine (PCV):",
"     </strong>",
"     <em>",
"      (Minimum age: 6 weeks)",
"      <br/>",
"     </em>",
"     <strong>",
"      Vaccination of persons with high-risk conditions:",
"     </strong>",
"     A single dose of PCV13 may be administered to previously unvaccinated children aged 6 through 18 years who have anatomic or functional asplenia (including sickle cell disease), HIV infection or an immunocompromising condition, cochlear implant or cerebrospinal fluid leak. See MMWR 2010; 59 (No. RR-11), available at",
"     <a href=\"file://www.cdc.gov/mmwr/pdf/rr/rr5911.pdf\" target=\"_blank\">",
"      www.cdc.gov/mmwr/pdf/rr/rr5911.pdf",
"     </a>",
"     . Administer PPSV23 at least 8 weeks after the last dose of PCV to children aged 2 years or older with high risk conditions (listed below).",
"     <br/>",
"     <strong>",
"      High risk conditions for pneumococcal vaccine:",
"     </strong>",
"     1) Immunocompetent children with chronic heart disease (particularly cyanotic congenital heart disease and cardiac failure); chronic lung disease (including asthma if treated with high-dose oral corticosteroid therapy), diabetes mellitus; cerebrospinal fluid leaks; or cochlear implant. 2) Children with anatomic or functional asplenia (including sickle cell disease and other hemoglobinopathies, congenital or acquired asplenia, or splenic dysfunction). 3) Children with immunocompromising conditions: HIV infection, chronic renal failure and nephrotic syndrome, diseases associated with treatment with immunosuppressive drugs or radiation therapy, including malignant neoplasms, leukemias, lymphomas and Hodgkin disease; or solid organ transplantation, congenital immunodeficiency.",
"     <br/>",
"     &yen;",
"     <strong>",
"      Pneumococcal polysaccharide vaccine (PPSV23):",
"     </strong>",
"     <em>",
"      (Minimum age: 2 years)",
"     </em>",
"     Administer PPSV23 at least 8 weeks after the last dose of PCV to children aged 2 years or older with high-risk conditions (listed above). A single revaccination with PPSV23 should be administered after 5 years to children with anatomic or functional asplenia (including sickle cell disease) or an immunocompromising condition.",
"     <br/>",
"     &Dagger;",
"     <strong>",
"      Hepatitis A (HepA) vaccine:",
"     </strong>",
"     For any person aged 2 years and older who has not already received the HepA vaccine series, 2 doses of HepA vaccine separated by 6 to 18 months may be administered if immunity against hepatitis A virus infection is desired.",
"     <br/>",
"     <strong>",
"      Special populations:",
"     </strong>",
"     Administer 2 doses of HepA vaccine at least 6 months apart to previously unvaccinated persons who live in areas where vaccination programs target older children, or who are at increased risk for infection.",
"     <br/>",
"     &dagger;",
"     <strong>",
"      Hepatitis B (HepB) vaccine:",
"     </strong>",
"     Unvaccinated persons should complete a 3-dose series. A 2-dose series (doses separated by at least 4 months) of adult formulation Recombivax HB is licensed for use in children aged 11 through 15 years.",
"     <br/>",
"     **",
"     <strong>",
"      Inactivated poliovirus (IPV) vaccine:",
"     </strong>",
"     A fourth dose is not necessary if the third dose was administered at age 4 years or older and at least 6 months after the previous dose. If both oral polio vaccine (OPV) and IPV were administered as part of a series, a total of 4 doses should be administered, regardless of the child's current age. IPV is not routinely recommended for US residents aged 18 years or older.",
"     <br/>",
"     <span class=\"double_bullet\">",
"      &bull;&bull;",
"     </span>",
"     <strong>",
"      Measles, mumps, and rubella (MMR) vaccine:",
"     </strong>",
"     Ensure that all school-aged children and adolescents have had 2 doses of MMR vaccine; the minimum interval between the 2 doses is 4 weeks.",
"     <br/>",
"     &Delta;&Delta;",
"     <strong>",
"      Varicella (VAR) vaccine:",
"     </strong>",
"     Ensure that all persons aged 7 through 18 years without evidence of immunity (see MMWR 2007; 56 [No. RR-4], available at",
"     <a href=\"file://www.cdc.gov/mmwr/pdf/rr/rr5604.pdf\" target=\"_blank\">",
"      www.cdc.gov/mmwr/pdf/rr/rr5604.pdf",
"     </a>",
"     ) have 2 doses of varicella vaccine. For children aged 7 through 12 years the recommended minimum interval between doses is 3 months (if the second dose was administered at least 4 weeks after the first dose, it can be accepted as valid); for persons aged 13 years and older, the minimum interval between doses is 4 weeks.",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from: Akinsanya-Beysolow I, Jenkins R, Meissner HC, Immunization Services Division, National Center for Immunization and Respiratory Diseases, CDC. Advisory Committee on Immunization Practices (ACIP) Recommended Immunization Schedule for Persons Aged 0 Through 18 Years - United States, 2013. MMWR Surveill Summ 2013; 62:2. Available at:&nbsp;",
"     <a href=\"file://www.cdc.gov/vaccines/schedules/downloads/child/0-18yrs-schedule.pdf\" target=\"_blank\">",
"      www.cdc.gov/vaccines/schedules/downloads/child/0-18yrs-schedule.pdf",
"     </a>",
"     (Accessed on February 3, 2013).",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_7_4218=[""].join("\n");
var outline_f4_7_4218=null;
var title_f4_7_4219="Guidelines on the internet";
var content_f4_7_4219=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F80337&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F80337&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Web sites for major guidelines",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle2_left\">",
"       National Guideline Clearinghouse",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       file://www.guideline.gov",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\">",
"       Agency for Healthcare Quality and Research",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       file://text.nlm.nih.gov/ahcpr/list.html",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\">",
"       Centers for Disease Control Guidelines for Sexually Transmitted Disease",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       file://www.cdc.gov/std/treatment/",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\">",
"       American College of Physicians/American Society of Internal Medicine",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       file://www.acponline.org",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\">",
"       American Cancer Society",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       file://cancer.org",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_7_4219=[""].join("\n");
var outline_f4_7_4219=null;
var title_f4_7_4220="Cyclosporine FK506 preparations";
var content_f4_7_4220=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F57518&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=9\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F57518&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=9\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Cyclosporine and tacrolimus preparations",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Cyclosporine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Oral",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Capsules: Liquid filled -&nbsp;25 mg, 50 mg, 100 mg",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Solution: 100 mg/mL in 50 mL bottles",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Topical",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Ophthalmic emulsion: 0.05 percent in 0.4 mL vials",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Parenteral",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Concentrate for injection: for IV infusion - 50 mg/mL in 5 mL ampules&nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Cyclosporine microemulsion",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Oral",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Capsules: 25 mg, 100 mg",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Solution: 100 mg/mL in 50 mL bottles",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Parenteral",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        No preparation available",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Tacrolimus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Oral",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Capsules: 0.5 mg, 1 mg, 5 mg",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Topical",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Ointment: 0.03 percent and 0.1 percent in 30 g and 60 g tubes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Parenteral",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Concentrate for injection: for IV infusion -&nbsp;5 mg/mL in 1 mL ampules",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_7_4220=[""].join("\n");
var outline_f4_7_4220=null;
var title_f4_7_4221="Differential of chronic fatigue";
var content_f4_7_4221=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F56425&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F56425&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Major causes of chronic fatigue",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\" class=\"container\">",
"     <tr>",
"      <td class=\"container\">",
"       <table cellspacing=\"0\">",
"        <tr>",
"         <td class=\"subtitle1_single\">",
"          Psychologic",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Depression",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Anxiety",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Somatization disorder",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Malnutrition or drug addiction",
"         </td>",
"        </tr>",
"        <tr>",
"         <td class=\"subtitle1_single\">",
"          Pharmacologic",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Hypnotics",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Antihypertensives",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Antidepressants",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Drug abuse and drug withdrawal",
"         </td>",
"        </tr>",
"        <tr>",
"         <td class=\"subtitle1_single\">",
"          Endocrine-metabolic",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Hypothyroidism",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Diabetes mellitus",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Apathetic hyperthyroidism",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Pituitary insufficiency",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Hypercalcemia",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Adrenal insufficiency",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Chronic renal failure",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Hepatic failure",
"         </td>",
"        </tr>",
"        <tr>",
"         <td class=\"subtitle1_single\">",
"          Neoplastic-hematologic",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Occult malignancy",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Severe anemia",
"         </td>",
"        </tr>",
"       </table>",
"      </td>",
"      <td class=\"container\">",
"       <table cellspacing=\"0\">",
"        <tr>",
"         <td class=\"subtitle1_single\">",
"          Infectious",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Endocarditis",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Tuberculosis",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Mononucleosis",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Hepatitis",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Parasitic disease",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          HIV infection",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Cytomegalovirus",
"         </td>",
"        </tr>",
"        <tr>",
"         <td class=\"subtitle1_single\">",
"          Cardiopulmonary",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Chronic heart failure",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Chronic obstructive pulmonary disease",
"         </td>",
"        </tr>",
"        <tr>",
"         <td class=\"subtitle1_single\">",
"          Connective tissue disease",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Rheumatoid disease",
"         </td>",
"        </tr>",
"        <tr>",
"         <td class=\"subtitle1_single\">",
"          Disturbed sleep",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Sleep apnea",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Esophageal reflux",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Allergic rhinitis",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Psychologic causes (see above)",
"         </td>",
"        </tr>",
"        <tr>",
"         <td class=\"subtitle1_single\">",
"          Idiopathic (diagnosis by exclusion)",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Idiopathic chronic fatigue",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Chronic fatigue syndrome",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Fibromyalgia",
"         </td>",
"        </tr>",
"       </table>",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from: Gorroll, AH, May, LA, Mulley, AG Jr (Eds), Primary Care Medicine: Office Evaluation and Management of the Adult Patient, 3rd ed, JB Lippincott, Philadelphia, 1995.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_7_4221=[""].join("\n");
var outline_f4_7_4221=null;
var title_f4_7_4222="Causes clitoromegaly";
var content_f4_7_4222=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F78311&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F78311&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Causes of clitoromegaly",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Condition",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"2\">",
"        Can present",
"       </td>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Comments and reference",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        At birth",
"       </td>",
"       <td class=\"subtitle2\">",
"        After birth",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle3_left\" colspan=\"4\">",
"        Virilized XX",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Congenital adrenal hyperplasia (CAH)",
"       </td>",
"       <td>",
"        Yes",
"       </td>",
"       <td>",
"        Yes",
"       </td>",
"       <td>",
"        21 alpha hydroxylase deficiency and 11 beta hydroxylase deficiency are the most common. Late presentation does occur",
"        <sup>",
"         [1,2]",
"        </sup>",
"        . (See \"Diagnosis of classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency\" and see \"Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency\").",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Maternal androgens or synthetic progestational agents",
"       </td>",
"       <td>",
"        Yes",
"       </td>",
"       <td>",
"        No",
"       </td>",
"       <td>",
"        (See \"Causes of gestational hyperandrogenism\")",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Placental aromatase enzyme deficiency",
"       </td>",
"       <td>",
"        Yes",
"       </td>",
"       <td>",
"        No",
"       </td>",
"       <td>",
"        Maternal virilization during pregnancy can be a clue to the diagnosis. (See \"Diagnosis and management of gestational hyperandrogenism\").",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Androgen-secreting tumors",
"       </td>",
"       <td>",
"        No",
"       </td>",
"       <td>",
"        Yes",
"       </td>",
"       <td>",
"        Ovarian",
"        <sup>",
"         [3]",
"        </sup>",
"        and adrenal",
"        <sup>",
"         [4]",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Hepatic dysfunction",
"       </td>",
"       <td>",
"        No",
"       </td>",
"       <td>",
"        Yes",
"       </td>",
"       <td>",
"        Report of 10-year-old girl with portal hypertension and impaired hepatic steroid metabolism",
"        <sup>",
"         [5]",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Exogenous androgens",
"       </td>",
"       <td>",
"        Yes",
"       </td>",
"       <td>",
"        Yes",
"       </td>",
"       <td>",
"        (Akcam 2003)",
"        <sup>",
"         [6]",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle3_left\" colspan=\"4\">",
"        Feminized XY (not true clitoromegaly, but small penis can appear as large clitoris)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Congenital adrenal hyperplasia (CAH)",
"       </td>",
"       <td>",
"        Yes",
"       </td>",
"       <td>",
"        Yes",
"       </td>",
"       <td>",
"        Examples include 17 hydroxylase deficiency, 3 beta hydroxysteroid deficiency. (See \"Uncommon causes of congenital adrenal hyperplasia\").",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Androgen insensitivity syndrome (aka testicular feminization syndrome)",
"       </td>",
"       <td>",
"        Yes",
"       </td>",
"       <td>",
"        Yes",
"       </td>",
"       <td>",
"        Complete insensitivity usually presents at birth, whereas partial insensitivity can present at birth or later",
"        <sup>",
"         [7,8]",
"        </sup>",
"        . (See \"Diagnosis and treatment of disorders of the androgen receptor\").",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        5-alpha reductase deficiency (5aRD)",
"       </td>",
"       <td>",
"        Yes",
"       </td>",
"       <td>",
"        No",
"       </td>",
"       <td>",
"        5aR converts testosterone to DHT. (See \"Steroid 5-alpha-reductase 2 deficiency\").",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle3_left\" colspan=\"4\">",
"        Other",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        True hermaphroditism",
"       </td>",
"       <td>",
"        Yes",
"       </td>",
"       <td>",
"        Yes",
"       </td>",
"       <td>",
"        Patients can be XX or XY. Genitalia can vary from ambiguous to isolated clitoromegaly",
"        <sup>",
"         [9]",
"        </sup>",
"        .",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Mixed gonadal dysgenesis",
"       </td>",
"       <td>",
"        Yes",
"       </td>",
"       <td>",
"        No",
"       </td>",
"       <td>",
"        Most patients are mosaics 45,XO/46,XY. (See \"Evaluation of the infant with ambiguous genitalia\").",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Neurofibromatosis",
"       </td>",
"       <td>",
"        Yes",
"       </td>",
"       <td>",
"        Yes",
"       </td>",
"       <td>",
"        Has been reported both with type 1 and type 2",
"        <sup>",
"         [10]",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Vascular malformation",
"       </td>",
"       <td>",
"        TP",
"       </td>",
"       <td>",
"        Yes",
"       </td>",
"       <td>",
"        Report of 5-year-old girl",
"        <sup>",
"         [11]",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Sebaceous cyst",
"       </td>",
"       <td>",
"        TP",
"       </td>",
"       <td>",
"        Yes",
"       </td>",
"       <td>",
"        Case report in adolescent girl",
"        <sup>",
"         [12]",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Idiopathic",
"       </td>",
"       <td>",
"        Yes",
"       </td>",
"       <td>",
"        Yes",
"       </td>",
"       <td>",
"        Report of two adults with acquired isolated clitoromegaly",
"        <sup>",
"         [13]",
"        </sup>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     TP: theoretically possible but no case report found.",
"    </div>",
"    <div class=\"reference\">",
"     References:",
"     <br>",
"      <ol>",
"       <li>",
"        Silverman K, Couey SM, Murmam D. Non-classic 21-hydroxylase deficiency in an 18-year-old female athlete. J Pediatr Adolesc gynecol. 2000; 13:96-7.",
"       </li>",
"       <li>",
"        Pang S. Congenital adrenal hyperplasia. Baillieres Clin Obstet Gynecol. 1997; 11:281-306.",
"       </li>",
"       <li>",
"        Sayer RA, Deutsch A, Hoffman MS. Clitoroplasty. Obstet Gynecol. 2007; 110:523-5.",
"       </li>",
"       <li>",
"        Wolthers OD, Cameron FJ, Scheimberg J, Honour JW, Hindmarsh PC, Savage MO, Stanhope RG, Brook CG. Androgen secreting adrenocortical tumors. Arch Dis Child, 1999; 80:46-50.",
"       </li>",
"       <li>",
"        Speiser PW, Susin M, Sassano H, Bohrer S, Markowitz J. Ovarian hyperthecosis in the setting of portal hypertension. J Clini Endocrinol Metab. 2000; 85:873-7.",
"       </li>",
"       <li>",
"        Akcam M, Topaloglu A. Extremely immature infant who developed clitoromegaly during the second month of her postnatal life probably due to frequent whole blood transfusion from an adult male. Pediatr Int. 2003; 45:347-8.",
"       </li>",
"       <li>",
"        Sultan C, Lumbroso S, Paris F, Jeandel C, Terouanne B, et al. Disorders of androgen action. Semin Reprod Med. 2002; 20:217-27.",
"       </li>",
"       <li>",
"        Chipashvili MK, Kristesashvili DI, Kopaliani NSh. Georgian Med News. 2006; 131:21-4.",
"       </li>",
"       <li>",
"        Yordam N, Alikasifoglu A, Kandemir N, Caglar M, Balci S. True hermaphroditism: clinical features, genetic variants and gonadal histology. J Pediatr Endocrinol Metab. 2001; 4:421-7.",
"       </li>",
"       <li>",
"        Yuksel H, Odabasi AR, Kafkas S, Onur E, Turgut M. Clitoromegaly in type 2 neurofibromatosis: a case report and review of the literature. Eur J Gynaecol Oncol. 2003; 24:447-51.",
"       </li>",
"       <li>",
"        Haritharan T, Islah M, Zulfiqar A, Thambi Dorai CR. Solitary vascular malformation of the clitoris. Med J Malaysia. 2006; 61:258-9.",
"       </li>",
"       <li>",
"        Guelinckx PJ, Sinsel NK. An unusual case of clitoral enlargement. Acta Chir Belg. 2002; 102:192-5.",
"       </li>",
"       <li>",
"        Copcu E, Aktas A, Sivrioglu N, Copcu O, Oztan Y. Idiopathic isolated clitoromegaly: a report of two cases. Reprod Health. 2004; 1:4.",
"       </li>",
"      </ol>",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_7_4222=[""].join("\n");
var outline_f4_7_4222=null;
var title_f4_7_4223="Infections after autologous HCT";
var content_f4_7_4223=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F64491&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F64491&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 526px\">",
"   <div class=\"ttl\">",
"    Timing of likely infections among autologous hematopoietic stem cell recipients receiving antimicrobial prophylaxis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 506px; height: 490px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_7_4223=[""].join("\n");
var outline_f4_7_4223=null;
